Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments
Open accessAbstract
Sarcopenic obesity and diabetes are two increasing health problems worldwide, which both share many common risk factors, such as aging, and general obesity. The pathogenesis of sarcopenic obesity includes aging, physical inactivity, malnutrition, low-grade inflammation, insulin resistance, and hormonal changes. Nevertheless, there are two major reasons to cause diabetes: impaired insulin secretion and impaired insulin action. Furthermore, the individual diagnosis of obesity and sarcopenia should be combined to adequately define sarcopenic obesity. Also, the diagnosis of diabetes includes fasting plasma glucose test (FPG), 2-h oral glucose tolerance test (OGTT), glycated hemoglobin (A1C), and random plasma glucose coupled with symptoms. Healthy diet and physical activity are beneficial to both sarcopenic obesity and diabetes, but there are only recommended drugs for diabetes. This review consolidates and discusses the latest research in pathogenesis, diagnosis, and treatments of diabetes and sarcopenic obesity.
AI snapshot
Written from the paper’s full text.
TL;DR
This narrative review consolidates pathogenesis, diagnosis, and treatment evidence for sarcopenic obesity (SO) and diabetes, emphasizing shared risk factors such as aging, obesity, low-grade inflammation, and insulin resistance. It concludes that diet and physical activity benefit both conditions, while pharmacological treatment is approved for diabetes but not for SO.
Key findings
- SO prevalence was reported as 12.6% in men and 33.5% in women in NHANES data, with an estimated 100–200 million affected people from 2016 to 2051; in 120 young adults with class II/III obesity, SO prevalence was 23.3% in women and 58.8% in men using appendicular skeletal muscle mass/weight × 100%.
- Diabetes prevalence was projected to rise from 422 million in 2014 to at least 592 million by 2035, with more than 50% of diabetics being obese; a meta-analysis of 606 articles found SO increased type 2 diabetes risk by almost 38% compared with excess weight or obesity alone.
- SO was associated with a 24% increased risk of all-cause mortality in a meta-analysis of 12 prospective cohort studies, with higher mortality when defined by mid-arm muscle circumference (HR 1.46, 95% CI 1.23–1.73) or muscle strength (HR 1.23, 95% CI 1.09–1.38) than by skeletal muscle mass (pooled HR 1.24, 95% CI 1.12–1.37, P < 0.001).
- For diabetes complications, diabetic kidney disease prevalence was 30% in T1D and 40% in T2D; diabetic retinopathy was expected to increase from 415 million in 2015 to 642 million by 2040; diabetic neuropathy prevalence varied from 10% to 90%; and diabetes was linked to a 49% increased colorectal cancer risk in men and a 27% increased breast cancer risk in women.
Methods
- Narrative review consolidating and discussing latest research on pathogenesis, diagnosis, and treatments of diabetes and SO.
- No primary sample or systematic search strategy is described; evidence is drawn from previously published studies, meta-analyses, RCTs, and reviews.
- Main analysis is a qualitative synthesis of mechanisms, diagnostic criteria, and treatment approaches, including dietary, physical activity, pharmacological, herbal, and acupuncture interventions.
Limitations
- The paper states there is currently no consistent diagnosis of SO; diagnosis varies with changes in obesity and sarcopenia definitions.
- The paper states that lack of proper RCTs makes expert opinion the major guideline for dietary interventions in SO, and there are currently no approved drugs for SO.
- The paper states that evidence for complementary and alternative treatments is of low overall quality with too few data, and that the mechanism linking SO and diabetes remains unclear; evident from the text, this is a narrative review without a described systematic search or formal quality appraisal, and it relies on heterogeneous SO definitions across cited studies.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 216 cited sources checked · 0 supported · 0 flagged
- Premisecitation
Loss of muscle mass leads to less insulin-responsive target tissue, resulting in a severe condition of insulin resistance.
“On the other hand, the loss of muscle mass leads to less insulin-responsive target tissue, resulting in a severe condition of insulin resistance (12, 13).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [12] Dominguez, 2007, The cardiometabolic syndrome and sarcopenic obesity in older persons , J Cardiometab Syndr. source
Not checked in the free run.
- cites [13] Baek, 2014, Sarcopenia and sarcopenic obesity and their association with dyslipidemia in Korean elderly men: the 2008–2010 Korea National health and nutrition examination survey, J Endocrinol Invest. source
Not checked in the free run.
- Premisecitation
More than 50% of diabetics are obese.
“it has been shown that more than 50% of the diabetics are obese (10).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] Khan, 2019, From pre-diabetes to diabetes: diagnosis, treatments and translational research, Medicina (Kaunas). source
Not checked in the free run.
- Premisenone given
Increasing fat mass facilitates various cytokines which accelerate the catabolism of muscles.
“Furthermore, the increasing fat mass facilitates various cytokines which accelerate the catabolism of muscles.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The vicious cycle of diabetes and sarcopenic obesity continues until more negative health consequences occur.
“Therefore, the vicious cycle continues until more negative health consequences occur (Figure 1).”
Quote in the paperSubstantial claim - Premisecitation
The effect of obesity on sarcopenia emerges as a new public health problem.
“Although the impact of sarcopenia has been well-demonstrated, the effect of obesity on it emerges as a new public health problem (2).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [2] Koliaki, 2019, Sarcopenic obesity: epidemiologic evidence, pathophysiology, therapeutic perspectives, Curr Obesity Rep. source
Not checked in the free run.
- Interpretationcitation
There is a good reason to suspect that diabetes and sarcopenic obesity have a strong relationship.
“Hence, there is a good reason to suspect that diabetes and SO have a strong relationship (11).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [11] Khadra, 2019, Association between sarcopenic obesity and higher risk of type 2 diabetes in adults: a systematic review and meta-analysis, World J Diabetes. source
Not checked in the free run.
- Premisereasoning
As less amount of fatty acid are oxidized in muscles, more fat mass deposits in visceral such as liver, heart, and spleen.
“As less amount of fatty acid are oxidized in muscles, more fat mass deposits in visceral such as liver, heart, and spleen.”
Quote in the paperSubstantial claim - Premisenone given
The reduction of fatty acid consumption is coupled with the increase of reactive oxygen species generation.
“Furthermore, the reduction of fatty acid consumption is coupled with the increase of reactive oxygen species generation.”
Quote in the paperSubstantial claim - Premisecitation
Oxidative stress is strongly associated with the expression of various inflammatory transcription factors, such as nuclear factor-kB (NF-kB) that modulates proteolytic pathways and promotes inflammation.
“Oxidative stress is strongly associated with the expression of various inflammatory transcription factors, such as nuclear factor-kB (NF- kB) that modulates proteolytic pathways and promotes inflammation (29–31).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [29] Jensen, 2008, Inflammation: roles in aging and sarcopenia, JPEN J Parenter Enteral Nutr. source
Not checked in the free run.
- cites [30] Meng, 2010, Oxidative stress, molecular inflammation and sarcopenia, Int J Mol Sci source
Not checked in the free run.
- cites [31] Liao, 2019, Reactive oxygen species: a volatile driver of field cancerization and metastasis, Mol Cancer. source
Not checked in the free run.
- Premisecitation
It is difficult to sustain muscle mass and strength with insufficient amount of protein intake.
“It is difficult to sustain muscle mass and strength with insufficient amount of protein intake (18).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [18] Muscariello, 2016, Dietary protein intake in sarcopenic obese older women, Clin Interv Aging. source
Not checked in the free run.
- Premisereasoning
The imbalance of energy intake and expenditure is linked to sarcopenic obesity, especially for the old.
“The imbalance of energy intake and expenditure is also linked to SO, especially for the old.”
Quote in the paperNot a substantial claim - Interpretationcitation
Low-grade inflammation is linked to sarcopenic obesity.
“which supports the theory that low-grade inflammation is linked to SO.”
Quote in the paperSubstantial claim - Premisenone given
Muscle can produce a variety of myokines such as myostatin and irisin.
“As an endocrine organ, the muscle can produce a variety of myokines such as myostatin and irisin.”
Quote in the paperSubstantial claim - Interpretationreasoning
Another vicious circle leading to sarcopenic obesity forms.
“Hence, another vicious circle leading to SO forms.”
Quote in the paperNot a substantial claim - Premisecitation
The loss of muscle strength and the gain of fat which characterize sarcopenic obesity is attributed by insulin resistance.
“Hence, the loss of muscle strength and the gain of fat which characterize SO is attributed by insulin resistance (41).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [41] Abbatecola, 2011, Discovering pathways of sarcopenia in older adults: a role for insulin resistance on mitochondria dysfunction, J Nutr Health Aging. source
Not checked in the free run.
- Premisecitation
An inflammatory state plays a significant role in the progression of sarcopenic obesity as well as the morbidity and mortality driven by sarcopenic obesity.
“Previous studies have indicated that an inflammatory state plays a significant role in the progression of SO as well as the morbidity and mortality driven by SO.”
Quote in the paperSubstantial claim - Interpretationcitation
Insulin resistance is involved in poor muscle mass and muscle strength, progressively resulting in sarcopenic obesity.
“Therefore, insulin resistance is involved in poor muscle mass and muscle strength, progressively resulting in SO.”
Quote in the paperSubstantial claim - Premisereasoning
Age-related sarcopenic obesity is usually due to the lack of physical activity.
“Age-related SO is usually due to the lack of physical activity.”
Quote in the paperNot a substantial claim - Premisecitation
Insulin resistance is correlated to mitochondrial dysfunction.
“Furthermore, insulin resistance is correlated to mitochondrial dysfunction as well.”
Quote in the paperSubstantial claim - Premisenone given
Old people obtain inadequate protein in their diet.
“On one hand, old people obtain inadequate protein in their diet.”
Quote in the paperSubstantial claim - Premisecitation
Due to decrease of outdoor physical activities, vitamin D produces less with scanty exposure of ultraviolet radiation.
“On the other hand, owing to decrease of outdoor physical activities, vitamin D produces less with scanty expose of ultraviolet radiation (19).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [19] Oh, 2016, The most effective factors to offset sarcopenia and obesity in the older Korean: physical activity, vitamin D, protein intake, Nutrition. source
Not checked in the free run.
- Premisenone given
Myokines can exacerbate insulin resistance.
“Particularly, myokines can exacerbate insulin resistance.”
Quote in the paperNot a substantial claim - Premisecitation
Inadequate vitamin D accelerates sarcopenic obesity.
“Hence, inadequate vitamin D accelerates SO (20).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20] Son, 2019, Sarcopenic obesity can be negatively associated with active physical activity and adequate intake of some nutrients in Korean elderly: findings from the Korea National Health and Nutrition Examination Survey (2008-2011), Nutr Res Pract. source
Not checked in the free run.
- Interpretationreasoning
The crosstalk between muscle and fat leads to muscle damage, eliciting sarcopenic obesity.
“Eventually, the crosstalk between muscle and fat leads to muscle damage, eliciting SO.”
Quote in the paperSubstantial claim - Premisenone given
Once the imbalance between the secretion of insulin and glucagon occurs, the levels of blood glucose skew improperly.
“Once the imbalance between the secretion of insulin and glucagon occurs, the levels of blood glucose skew improperly as well.”
Quote in the paperNot a substantial claim - Interpretationreasoning
This leads to the destruction and dysfunction of certain cells, like islet β cells that produce insulin.
“This leads to the destruction and dysfunction of certain cells, like islet β cells that produce insulin.”
Quote in the paperSubstantial claim - Premisecitation
The characteristic may attribute to physical disability and metabolic syndromes.
“Furthermore, the characteristic may attribute to physical disability and metabolic syndromes, which has been clarified in another Korean study (57).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] Kim, 2010, Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS), Diabetes Care. source
Not checked in the free run.
- Premisecitation
The accumulation of free fatty acids in the islet β cells accelerates the production of NO, which causes the apoptosis of β cells.
“The accumulation of free fatty acids in the islet β cells accelerates the production of NO, which causes the apoptosis of β cells.”
Quote in the paperNot a substantial claim - Premisecitation
According to different definition of sarcopenic obesity, the risk of all-cause mortality changes.
“Noteworthily, according to different definition of SO, the risk of all-cause mortality changes.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [52] Tian, 2016, Association of sarcopenic obesity with the risk of all-cause mortality: a meta-analysis of prospective cohort studies, Geriatr Gerontol Int. source
Not checked in the free run.
- Premisecitation
The function of β cells and α cells changes with the glucose environment in an individual's body.
“The function of β cells and α cells changes with the glucose environment in an individual's body (69, 70).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [69] Giwa, 2020, Current understandings of the pathogenesis of type 1 diabetes: genetics to environment, World J Diabetes. source
Not checked in the free run.
- cites [70] Kautzky-Willer, 2016, Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus, Endocr Rev. source
Not checked in the free run.
- Premisecitation
Long chain saturated fatty acids can inhibit the expression of adenine nucleotide translocator.
“Furthermore, long chain saturated fatty acids can inhibit the expression of adenine nucleotide translocator.”
Quote in the paperSubstantial claim - Premisecitation
Metabolic disorders including cardiometabolic syndrome (CMS), diabetes, cardiovascular disease (CVD), and cancer are common comorbidities of sarcopenic obesity.
“Secondly, metabolic disorders including cardiometabolic syndrome (CMS), diabetes, cardiovascular disease (CVD), and cancer are common comorbidities of SO (54, 55).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [54] Hong, 2020, Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences, Int J Mol Sci. source
Not checked in the free run.
- cites [55] Liao, 2019, Cancer-associated fibroblasts in tumor microenvironment–Accomplices in tumor malignancy, Cell Immunol. source
Not checked in the free run.
- Premisecitation
Muscle mass and strength weaken with the reduced testosterone and estrogen concentrations.
“Hence, the muscle mass and strength weaken with the reduced testosterone and estrogen concentrations (50).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [50] Sipilä, 2013, Sex hormones and skeletal muscle weakness, Biogerontology. source
Not checked in the free run.
- Premisecitation
The chronic activation of the innate immune system, leading to intra-islet inflammation, also seems to be the key part of β cells apoptosis.
“In fact, the chronic activation of the innate immune system, leading to intra-islet inflammation also seems to be the key part of β cells apoptosis (77).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [77] Donath, 2003, Inflammatory mediators and islet β-cell failure: a link between type 1 and type 2 diabetes source
Not checked in the free run.
- Premisecitation
Sarcopenic obesity is overtly associated with an increased risk of all-cause mortality.
“Firstly, SO is overtly associated with an increased risk of all-cause mortality.”
Quote in the paperNot a substantial claim - Premisecitation
Adverse clinical cancer outcomes are reported to be relevant to sarcopenic obesity, especially with respect to dose-limiting toxicity, surgical complications, physical disability, and shorter survival.
“Moreover, adverse clinical cancer outcomes reported to be relevant to SO, especially with respect to dose-limiting toxicity, surgical complications, physical disability, and shorter survival (59–61).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [59] Baracos, 2018, Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy, Ann Oncol. source
Not checked in the free run.
- cites [60] Carneiro, 2016, Clinical implications of sarcopenic obesity in cancer, Curr Oncol Rep. source
Not checked in the free run.
- cites [61] Gonzalez-Molina, 2019, MMP14 in sarcoma: a regulator of tumor microenvironment communication in connective tissues, Cells. source
Not checked in the free run.
- Premisecitation
Other hormones, including IGF-1, growth hormone, testosterone, and estrogen, regulate the anabolic and catabolic progressions in muscle.
“Other hormones, including insulin-like growth factors-1 (IGF-1), growth hormone, testosterone, and estrogen, also regulate the anabolic and catabolic progressions in muscle (46, 47).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisenone given
The cluster of abdominal obesity, hyperglycemia, hyperinsulinemia, dyslipidemia, and hypertension that composes cardiometabolic syndrome progressively leads to diabetes and cardiovascular disease.
“The cluster of abdominal obesity, hyperglycemia, hyperinsulinemia, dyslipidemia, and hypertension that composes CMS progressively leads to diabetes and CVD.”
Quote in the paperSubstantial claim - Premisecitation
Sarcopenic obesity is an indicator of probable cognitive impairment in the geriatric population.
“A cross-sectional study has evaluated the association between SO and cognitive function in geriatric population, and found that SO is an indicator of probable cognitive impairment (65).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [65] Magdalena, 2018, Sarcopenic obesity and cognitive performance, Clin Interv Aging. source
Not checked in the free run.
- Premisenone given
The islet β cells are especially sensitive to ROS because of their low inherent level of antioxidant enzymes.
“Furthermore, the islet β cells are especially sensitive to ROS because of their low inherent level of antioxidant enzymes.”
Quote in the paperNot a substantial claim - Premisecitation
Sarcopenic obesity increases the risk of type 2 diabetes by almost 38% compared to individuals with excess weight or obesity alone.
“A meta-analysis including 606 articles has demonstrated that SO increases the risk of T2D by almost 38% compared to individuals with excess weight or obesity alone (11).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Khadra, 2019, Association between sarcopenic obesity and higher risk of type 2 diabetes in adults: a systematic review and meta-analysis, World J Diabetes. source
Not checked in the free run.
- Interpretationreasoning
Aberrant hormonal changes with age exacerbate sarcopenic obesity.
“Therefore, aberrant hormonal changes with age exacerbate SO.”
Quote in the paperSubstantial claim - Premisecitation
Most studies support that sarcopenic obesity causes physical disability.
“Finally, even if there is no discrepancies between SO group and other groups of physical capacity found in a study (62), most studies support that SO causes physical disability.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [62] Brochu, 2012, Sarcopenic/obesity and physical capacity in older men and women: data from the nutrition as a determinant of successful aging (NuAge)-the Quebec longitudinal study, Obesity(Sliver Spring). source
Not checked in the free run.
- Premisecitation
All-cause mortality is higher based on the criteria of mid-arm muscle circumference or muscle strength (HR 1.46, 95% CI 1.23-1.73 and 1.23, 1.09-1.38, respectively) rather than on the definition of skeletal muscle mass (pooled HR 1.24, 95% CI 1.12-1.37, P < 0.001).
“Specifically, all-cause mortality is higher basing on the criteria of mid-arm muscle circumference or muscle strength (HR 1.46, 95% CI 1.23–1.73 and 1.23, 1.09–1.38, respectively) rather than on the definition of skeletal muscle mass (pooled HR 1.24, 95% CI 1.12–1.37, P < 0.001) (52).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [52] Tian, 2016, Association of sarcopenic obesity with the risk of all-cause mortality: a meta-analysis of prospective cohort studies, Geriatr Gerontol Int. source
Not checked in the free run.
- Premisecitation
Diabetic individuals with liver cancer and bladder cancer are associated with a poor survival compared with non-diabetic subjects.
“Besides, diabetic individuals with liver cancer and bladder cancer are associated with a poor survival compared with non-diabetic subjects (122).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [122] Wang, 2020, Diabetes and cancer: epidemiological and biological links, World J Diabetes. source
Not checked in the free run.
- Premisecitation
To sustain a stable levels of blood glucose, islet β cells secret excessive insulin to compensate, leading to hyperinsulinemia.
“In order to sustain a stable levels of blood glucose, islet β cells secret excessive insulin to compensate, leading to hyperinsulinemia (86).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [86] Nolan, 2019, Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: time for a conceptual framework shift, Diab Vasc Dis Res. source
Not checked in the free run.
- Premisecitation
The elevated amount of these components stimulates several signaling pathways such as inhibitor kappa beta kinase beta (IKKβ), Jun N-terminal kinase (JNK), and NF-κB signaling pathways to induce the development of insulin resistance.
“The elevated amount of these components stimulates several signaling pathways such as inhibitor kappa beta kinase beta (IKKβ), Jun N-terminal kinase (JNK), and NF-κB signaling pathways to induce the development of insulin resistance (92, 93).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [92] Akash, 2018, Tumor necrosis factor-alpha: role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus, J Cell Biochem. source
Not checked in the free run.
- cites [93] Gomes, 2019, Immunoinflammatory mediators in the pathogenesis of diabetes mellitus, Einstein (Sao Paulo). source
Not checked in the free run.
- Premisereasoning
Increased insulin content results in less affinity of insulin receptor (IR) thus, cells (major muscle) gradually become insensitive to insulin.
“Increased insulin content results in less affinity of insulin receptor (IR) thus, cells (major muscle) gradually become insensitive to insulin.”
Quote in the paperNot a substantial claim - Premisecitation
Chronically excessive levels of ROS can cause the loss of transcription factors PDX-1 and MsfA, disturbing the expression of insulin gene.
“Moreover, chronically excessive levels of ROS can cause the loss of transcription factors PDX-1 and MsfA, disturbing the expression of insulin gene (84).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [84] Robertson, 2007, Chronic oxidative stress as a mechanism for glucose toxicity of the beta cell in type 2 diabetes, Cell Biochem Biophys. source
Not checked in the free run.
- Premisecitation
Indian patients with type 2 diabetes are as twice likely to develop coronary artery diseases as white Europeans who have type 2 diabetes.
“However, Indian patients with T2D are as twice likely to develop coronary artery diseases as white Europeans who have T2D (115).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [115] Forouhi, 2006, Do known risk factors explain the higher coronary heart disease mortality in South Asian compared with European men? prospective follow-up of the Southall and Brent studies, UK, Diabetologia. source
Not checked in the free run.
- Premisecitation
Multiple factors, particular obesity, increase the levels of adipocytes, inflammatory cytokines (IL-1, IL-6, and TNFα).
“Furthermore, there are multiple factors, particular obesity, increase the levels of adipocytes, inflammatory cytokines (IL-1, IL-6, and TNFα) (91).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [91] Polsky, 2015, Obesity, insulin resistance, and type 1 diabetes mellitus, Curr Opin Endocrinol Diabetes Obes. source
Not checked in the free run.
- Premisecitation
Diabetes is considered as an independent risk factor for increased rates of various types of cancer.
“Numerous epidemiological evidences have indicated that diabetes is considered as an independent risk factor for increased rates of various types of cancer.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Diabetic neuropathy extremely influences the quality of life in diabetic people.
“Therefore, diabetic neuropathy extremely influences the quality of life in diabetic people.”
Quote in the paperNot a substantial claim - Premisecitation
For endometrial cancer, the new-onset diabetics (<5 years) have a two-fold risk compared with those with long-standing diabetes (≥5 years).
“For endometrial cancer, the new-onset diabetics (<5 years) have a two-fold risk compared with those with long-standing diabetes (≥5 years) (121).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [121] Saltzman, 2008, Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors, Am J Epidemiol. source
Not checked in the free run.
- Premisecitation
Any impairments occur on main phosphorylation sites will reduce insulin receptor tyrosine kinase activity, eventually affecting the insulin function.
“Therefore, any impairments occur on main phosphorylation sites will reduce insulin receptor tyrosine kinase activity, eventually affecting the insulin function (88–90).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [88] Abdul-Ghani, 2010, Pathogenesis of insulin resistance in skeletal muscle, J Biomed Biotechnol. source
Not checked in the free run.
- cites [89] Kasuga, 2019, Structure and function of the insulin receptor-a personal perspective, Proc JPN Acad B Phys Biol Sci. source
Not checked in the free run.
- cites [90] De Meyts, 2004, Insulin and its receptor: structure, function and evolution, Bioessays. source
Not checked in the free run.
- Premisecitation
Distal symmetric polyneuropathy mainly contributes to disability in diabetics, stemming from gait disturbance, fall-related injury, and foot ulceration and amputation.
“Meanwhile, distal symmetric polyneuropathy mainly contributes to disability in diabetics, stemming from gait disturbance, fall-related injury, and foot ulceration and amputation (109).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [109] Lechleitner, 2019, Diabetic neuropathy and diabetic foot syndrome (Update 2019), Wien Klin Wochenschr. source
Not checked in the free run.
- Premisecitation
25-hydroxyvitamin D3 can indirectly impact muscle function because its free metabolite is more closely related to body fat than muscle gene expression.
“A study has verified that 25-hydroxyvitamin D3 can indirectly impact muscle function as its free metabolite is more closely related to body fat than muscle gene expression (155).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [155] Hassan-Smith, 2017, 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 exert distinct effects on human skeletal muscle function and gene expression, PLoS ONE. source
Not checked in the free run.
- Premisecitation
Cutoffs of BF% (Body Fat Percentage) or other adiposity indices have been regarded as useful outcomes measure of obesity.
“Alternatively, cutoffs of BF% (Body Fat Percentage) or other adiposity indices have been regarded as useful outcomes measure of obesity (126, 127).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [126] Weir, 2020, BMI Classification Percentile And Cut Off Points
Not checked in the free run.
- cites [127] Panuganti, 2020, Obesity
Not checked in the free run.
- Interpretationnone given
Acute caloric restriction could promote proteolysis and negatively affect muscle protein synthesis, resulting in a further reduction of muscle mass.
“As acute caloric restriction could promote proteolysis and negatively affect muscle protein synthesis, resulting in a further reduction of muscle mass, acute caloric restriction is not recommended.”
Quote in the paperSubstantial claim - Premisecitation
Overestimation is accompanied with a poor distinction between extracellular and intracellular fluid.
“Hence, an overestimation is accompanied with a poor distinction between extracellular and intracellular fluid (133).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [133] Yu, 2016, The performance of five bioelectrical impedance analysis prediction equations against dual x-ray absorptiometry in estimating appendicular skeletal muscle mass in an adult australian population, Nutrients. source
Not checked in the free run.
- Premisecitation
Dietary intervention is an important modifiable factor to reduce the incidence of cardiovascular diseases in diabetics.
“Furthermore, dietary intervention is an important modifiable factor to reduce the incidence of cardiovascular diseases in diabetics (161).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [161] 2017, Curr Obes Rep. source
Not checked in the free run.
- Premisecitation
Anthropometric measurements, such as mid-upper arm circumference, calf circumference, and skin fold thickness, are inaccurate.
“In spite of the widespread use of anthropometric measurements, such as mid-upper arm circumference, calf circumference, and skin fold thickness, they are inaccurate (135).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [135] Choi, 2016, Sarcopenia and sarcopenic obesity, Korean J Inter Med. source
Not checked in the free run.
- Premisecitation
Macrobiotic and vegan diets were beneficial to glycemic control.
“The macrobiotic and vegan diets were beneficial to glycemic control, while the vegetarian diet demonstrated better weight loss and insulin sensitivity.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [159] Papamichou, 2019, Dietary patterns and management of type 2 diabetes: a systematic review of randomised clinical trials, Nutr Metab Cardiovasc Dis. source
Not checked in the free run.
- Premisecitation
Intake of low glycemic food including cereal fiber or a mixture of whole grain and bran can decrease 18-40% of risk for diabetics.
“The intake of low glycemic food including cereal fiber or a mixture of whole grain and bran can decrease 18–40% of risk for diabetics (157).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [157] Cho, 2013, Am J Clin Nutr. source
Not checked in the free run.
- Premisecitation
In a systematic review of randomized clinical trials, there were no evident differences between low carbohydrate diets and low-fat diets in glycemic control, weight, and lipids.
“However, there were no evident differences of low carbohydrate diets and low-fat diets in glycemic control, weight and lipids.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [159] Papamichou, 2019, Dietary patterns and management of type 2 diabetes: a systematic review of randomised clinical trials, Nutr Metab Cardiovasc Dis. source
Not checked in the free run.
- Premisecitation
Sufficient protein intake is able to preserve muscle mass in older women with sarcopenic obesity.
“A study assessed the effect of a diet moderately rich in proteins on lean mass in SO older women, and has indicated that sufficient protein intake is able to preserve muscle mass in older women with SO (18).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [18] Muscariello, 2016, Dietary protein intake in sarcopenic obese older women, Clin Interv Aging. source
Not checked in the free run.
- Premisecitation
Vitamin D has the capability of regulating bioactive metabolites and thus improving muscle function.
“Besides, studies have elucidated that vitamin D has the capability of regulating bioactive metabolites, and thus, improving muscle function (156).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [156] Sohl, 2013, Vitamin D status is associated with physical performance: the results of three independent cohorts, Osteoporos Int. source
Not checked in the free run.
- Premisecitation
There is currently no recommended or approved pharmacological intervention for sarcopenic obesity, including in diabetics with sarcopenic obesity.
“Although there are various approved and effective drugs for diabetes, there is currently no recommended pharmacological intervention for SO, not even for diabetics with SO.”
- Also stated in: § Conventional Treatments for Sarcopenic Obesity and Diabetes · plain
“In spite of many novel pharmacological interventions are under investigation, such as testosterone supplement, selective androgen receptor modulators, and myostatin inhibitors, there is currently no approved drugs for SO (176–178).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [176] Ferrando, 2002, Testosterone administration to older men improves muscle function: molecular and physiological mechanisms, Am J Physiol Endocrinol Metab. source
Not checked in the free run.
- cites [177] Papanicolaou, 2013, A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia, J Nutr Health Aging. source
Not checked in the free run.
- cites [178] J.-Camporez, 2016, Anti-myostatin antibody increases muscle mass and strength and improves insulin sensitivity in old mice, Proc Natl Acad Sci USA. source
Not checked in the free run.
- Also stated in: § Conventional Treatments for Sarcopenic Obesity and Diabetes · plain
- Premisecitation
The risk of diabetes reduces by 26% due to consumption of one sugar-containing beverage more than 1 month compared to one per day.
“Moreover, the risk of diabetes reduces by 26% due to the consumption of one sugar-containing beverage more than 1 month compared to one per day (158).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [158] Malik, 2010, Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis, Diabetes care. source
Not checked in the free run.
- Premisecitation
A Mediterranean diet showed greater regulation of A1C levels.
“Besides, the Mediterranean diet showed a greater regulation of A1C levels.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [159] Papamichou, 2019, Dietary patterns and management of type 2 diabetes: a systematic review of randomised clinical trials, Nutr Metab Cardiovasc Dis. source
Not checked in the free run.
- Interpretationreasoning
A combination of physical activity and dietary intervention is a more effective strategy to treat sarcopenic obesity.
“A combination of physical activity and dietary intervention is a more effective strategy to treat SO.”
Quote in the paperSubstantial claim - Premisecitation
Increased dietary protein can prevent weight loss-induced sarcopenia.
“Increased dietary protein can prevent weight loss-induced sarcopenia.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [149] Deutz, 2014, Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group, Clin Nutr. source
Not checked in the free run.
- cites [150] Bauer, 2013, Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group, J Am Med Direct Assoc. source
Not checked in the free run.
- cites [151] Paddon-Jones, 2009, Dietary protein recommendations and the prevention of sarcopenia, Curr Opin Cin Nutr Metab Care. source
Not checked in the free run.
- Premisecitation
Chronic caloric restriction might increase muscle protein synthesis rather than downregulate it.
“In contrast, chronic caloric restriction might increase muscle protein synthesis rather than downregulate (144, 145).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [144] Heymsfield, 2014, Weight loss composition is one-fourth fat-free mass: a critical review and critique of this widely cited rule, Obes Rev. source
Not checked in the free run.
- cites [145] Freiberger, 2015, Sarcopenic obesity and complex interventions with nutrition and exercise in community-dwelling older persons – a narrative review, Clin Intervent Aging. source
Not checked in the free run.
- Premisecitation
In that RCT, grip strength and knee extensor performance of the resistance group were superior to those of the other groups.
“Noteworthy, the grip strength and knee extensor performance of resistance group were superior to those of the other groups (170).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [170] Chen, 2017, Effects of different types of exercise on body composition, muscle strength, and igf-1 in the elderly with sarcopenic obesity, J Am Geriatr Soc. source
Not checked in the free run.
- Interpretationcitation
Resistance training combined with aerobic training is the most effective way to alleviate physical disability.
“Thus, resistance training combined aerobic training is the most effective way to alleviated physical disability (171).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [171] Villareal, 2017, Aerobic or resistance exercise, or both, in dieting obese older adults, N Engl J Med. source
Not checked in the free run.
- Premisecitation
In that RCT, there was a significant absolute mean change of A1C in the combination training group.
“however, there was a significant absolute mean change of A1C in the combination training group.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [175] Church, 2010, Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial, JAMA. source
Not checked in the free run.
- Premisecitation
α-Glucosidase inhibitors do not increase insulin sensitization.
“Whereas, it should be noted that they do not increase insulin sensitization (190)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [190] Shimabukuro, 2017, α-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) study, Cardiovasc Diabetol. source
Not checked in the free run.
- Premisecitation
Exercise, particularly resistance training, plays a key part in improving body composition and physical performance in patients with sarcopenic obesity.
“A meta-analysis involving 14 RCTs and a quasi-experimental trial has clarified that exercise, particularly resistance training plays a key part in improving body composition and physical performance in patients with SO (169).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [169] Hsu, 2019, Effects of exercise and nutritional intervention on body composition, metabolic health, and physical performance in adults with sarcopenic obesity: a meta-analysis, Nutrients. source
Not checked in the free run.
- Premisecitation
After 3 weeks of wild ginseng complex intervention, two patients had an increase in muscle mass, protein content, and basal metabolic rate.
“After 3 weeks of WGC intervention, the two patients had an increase in muscle mass, protein content, and basal metabolic rate.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [195] Hwang, 2018, Effects of pharmacopuncture with wild ginseng complex in 2 elderly patients with obesity: case report, Medicine (Baltimore). source
Not checked in the free run.
- Premisecitation
Three major herbal medicines including Zuo Gui Wan, red raspberry leaves, and Orthosiphon stamineus were found beneficial to gestational diabetes by controlling glucose.
“In another study, three major herbal medicine including Zuo Gui Wan, red raspberry leaves, and Orthosiphon stamineus were found beneficial to gestational diabetes by controlling glucose (196).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [196] Xu, 2019, Evaluating traditional chinese medicine and herbal products for the treatment of gestational diabetes mellitus, J Diabetes Res. source
Not checked in the free run.
- Premisecitation
A systematic review disapproves of acarbose dosages higher than 50 mg three times a day, as there is no better effect on glycated hemoglobin.
“a systematic review disapproves of acarbose dosages higher than 50 mg (three times a day), as there is no better effects on glycated hemoglobin (191).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [191] van de Laar, 2005, Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis, Diabetes Care. source
Not checked in the free run.
- Premisecitation
Physical activity is an effective regimen to lower the risk of developing diabetes by improving β-cell function.
“Several studies have demonstrated that physical activity is an effective regimen to lower the risk of developing diabetes by improving the β-cell function (172).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [172] Aune, 2015, Physical activity and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis, Eur J Epidemiol. source
Not checked in the free run.
- Premisecitation
In an RCT of 60 men and women, skeletal muscle mass, body fat mass, ASM/weight %, and visceral fat area of treatment groups exhibited better results than the control group.
“an RCT, allocating 60 men and women to four groups (resistance training, aerobic training, combination training, and control), has found that the skeletal muscle mass, body fat mass, ASM/weight % and visceral fat area of treatment groups exhibited better results than control group.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [170] Chen, 2017, Effects of different types of exercise on body composition, muscle strength, and igf-1 in the elderly with sarcopenic obesity, J Am Geriatr Soc. source
Not checked in the free run.
- Premisecitation
In a clinical study of obese older people, the physical performance test score was highest in the combination group (21% increase) compared to the resistance group (14% increase) and aerobic group (14% increase).
“It has revealed that the physical performance test score was the highest in the combination group (21% increase) compared to the resistance group (14% increase) and aerobic group (14% increase).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [171] Villareal, 2017, Aerobic or resistance exercise, or both, in dieting obese older adults, N Engl J Med. source
Not checked in the free run.
- Premisecitation
In that study, peak oxygen consumption increased most in the aerobic group (18% increase) compared to the combination group (17% increase) and resistance group (8% increase).
“While peak oxygen consumption (milliliters per kilogram of body weight per minute) increased most in the aerobic group (18% increase) compared to the combination group (17% increase) and resistance group (8% increase).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [171] Villareal, 2017, Aerobic or resistance exercise, or both, in dieting obese older adults, N Engl J Med. source
Not checked in the free run.
- Interpretationcitation
Effective management of diabetics with sarcopenic obesity using herbal medicine and derivatives may be plausible.
“Hence, effective management of diabetics with SO using herbal medicine and derivatives may be plausible but more supportive evidences are still required.”
Quote in the paperSubstantial claim - Premisecitation
High-intensity interval training is strongly associated with improvement of β-cell function in patients with type 2 diabetes.
“Another study also has confirmed that high-intensity interval training is strongly associated with the improvement of β-cell function in patients with T2D.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [174] Nieuwoudt, 2017, Functional high-intensity training improves pancreatic β-cell function in adults with type 2 diabetes, Am J Physiol Endocrinol Metab. source
Not checked in the free run.
- Interpretationreasoning
Because of their impact on weight reduction, incretins may find increasing use in diabesity.
“Because of the impact on weight reduction, incretins may find increasing use in diabesity, which is the coexistence of diabetes and obesity (193).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [193] Chia, 2020, Incretins in obesity and diabetes, Ann N Y Acad Sci. source
Not checked in the free run.
- Interpretationcitation
Wild ginseng complex intervention may be a new alternative treatment for age-related sarcopenic obesity.
“Therefore, WGC intervention may be a new alternative treatment for age-related sarcopenic obesity but more studies using larger samples are required to support this (195).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [195] Hwang, 2018, Effects of pharmacopuncture with wild ginseng complex in 2 elderly patients with obesity: case report, Medicine (Baltimore). source
Not checked in the free run.
- Premisecitation
SGLT2 inhibitors can positively affect cardiovascular diseases due to sodium decrease, uric acid absorption, and blood pressure reduction.
“Meanwhile, they can also positively affect cardiovascular diseases due to sodium decrease, uric acid absorption, and blood pressure reduction (194).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [194] List, 2011, Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans, Kidney Int. source
Not checked in the free run.
- Premisecitation
In that RCT, the combination training group had maximal progression of oxygen consumption compared to other groups.
“Moreover, the combination training group had a maximal progression of oxygen consumption compared to other groups.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [175] Church, 2010, Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial, JAMA. source
Not checked in the free run.
- Premisecitation
In that RCT, all three exercise groups decreased waist circumference by 1.9-2.8 cm as compared to the control group.
“All three exercise groups decreased waist circumference by 1.9–2.8 cm as compared to the control group.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [175] Church, 2010, Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial, JAMA. source
Not checked in the free run.
- Premisecitation
Pioglitazone and troglitazone have the effect of controlling the progression of gestational diabetes.
“Pioglitazone and troglitazone, belonging to thiazolidinediones, have the effect of controlling the progression on gestational diabetes (187, 188).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [187] Berkowitz, 1996, Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM, Diabetes. source
Not checked in the free run.
- cites [188] Xiang, 2006, Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes, Diabetes. source
Not checked in the free run.
- Premisecitation
A meta-analysis of randomized controlled trials confirmed that acupuncture should be recommended as a complementary treatment in type 2 diabetes control, particularly with obesity or other metabolic disorders.
“Besides, a meta-analysis of randomized controlled trials has confirmed that acupuncture should be recommended as a complementary treatment in T2D control, particularly with obesity or other metabolic disorders (195).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [195] Hwang, 2018, Effects of pharmacopuncture with wild ginseng complex in 2 elderly patients with obesity: case report, Medicine (Baltimore). source
Not checked in the free run.
- Interpretationcitation
Diabetes is associated with increased risk of sarcopenic obesity.
“indicating that diabetes is associated with increased risk of SO.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [57] Kim, 2010, Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS), Diabetes Care. source
Not checked in the free run.
- Premisecitation
Studies have suggested that acupuncture's mechanism on diabetes may be related to adjusting nerve conduction, modulating signal pathways, regulating hormonal level, and ameliorating oxidative stress.
“Although the underlying mechanism of acupuncture on diabetes remains unclear, studies have suggested that it may be related to adjust nerve conduction, modulate signal pathways, regulate hormonal level, and ameliorate oxidative stress level (200).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [200] Feng, 2018, Acupoint therapy on diabetes mellitus and its common chronic complications: a review of its mechanisms, Biomed Res Int. source
Not checked in the free run.
- Interpretationnone given
Dietary intervention and physical activity are considered prevalently effective treatments for diabetics with sarcopenic obesity.
“different treatment options have been exhibited that dietary intervention and physical activity are considered as prevalently effective treatments for diabetics with SO”
Quote in the paperSubstantial claim - Interpretationnone given
Some complementary and alternative interventions have shown some positive effects on sarcopenic obesity and diabetes.
“some complementary and alternative interventions have shown some positive effects on SO and diabetes.”
Quote in the paperNot a substantial claim - Premisecitation
In that RCT, the combination group can increase muscle mass in a shorter time.
“Moreover, the combination group can increase muscle mass in a shorter time (197).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [197] Zhou, 2018, The effects of electrical acupuncture and essential amino acid supplementation on sarcopenic obesity in male older adults: a randomized control study, Obes Facts. source
Not checked in the free run.
- Premisecitation
Low-grade inflammation plays a crucial role in the pathogenesis of diabetes.
“SO combines sarcopenia and obesity, and low-grade inflammation plays a crucial role in the pathogenesis of diabetes (11).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [11] Khadra, 2019, Association between sarcopenic obesity and higher risk of type 2 diabetes in adults: a systematic review and meta-analysis, World J Diabetes. source
Not checked in the free run.
- May combine two claims. 92
- Classified as probably not a substantial claim. 38
May combine two claims.
PremisecitationDiabetes is linked to impaired insulin secretion, impaired insulin action, or both.
“In the case of diabetes, it may be linked to impaired insulin secretion (insulin deficiency), impaired insulin action (insulin resistance), or both (71).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [71] Liu, 2020, Past, present and future of latent autoimmune diabetes in adults, Diabetes Metab Res Rev. source
Not checked in the free run.
May combine two claims.
PremisecitationAging is associated with a decrease in muscle mass and strength and an increase in body fat mass, leading to frailty, falls, disability, social isolation, and hospitalization.
“Aging is associated with the decrease in muscle mass and strength and the increase in body fat mass, which leads to frailty, falls, disability, social isolation, and hospitalization.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [1] Zamboni, 2019, Sarcopenia and obesity, Curr Opin Clin Nutr. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenThe diagnosis of diabetes includes fasting plasma glucose test (FPG), 2-h oral glucose tolerance test (OGTT), glycated hemoglobin (A1C), and random plasma glucose coupled with symptoms.
“Also, the diagnosis of diabetes includes fasting plasma glucose test (FPG), 2-h oral glucose tolerance test (OGTT), glycated hemoglobin (A1C), and random plasma glucose coupled with symptoms.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenThe pathogenesis of sarcopenic obesity includes aging, physical inactivity, malnutrition, low-grade inflammation, insulin resistance, and hormonal changes.
“The pathogenesis of sarcopenic obesity includes aging, physical inactivity, malnutrition, low-grade inflammation, insulin resistance, and hormonal changes.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationCompared to simple sarcopenia or obesity alone, the medical sequelae related to sarcopenic obesity are much greater, causing significantly higher healthcare costs.
“Compared to simple sarcopenia or obesity alone, the medical sequelae related to SO are much greater, causing significantly higher healthcare costs (4).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Xie, 2019, Sarcopenic obesity: research advances in pathogenesis and diagnostic criteria, Aging Clin Exp Res source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe percentage of diabetics rises with age.
“A study in America has suggested that the percentage of diabetics rises with age (9).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] Fang, 2018, Trends in the prevalence of diabetes among US adults: 1999-2016, Am J Prevent Med. source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based). May combine two claims.
Premisenone givenInsulin loses the function to enhance cellular glucose uptake and utilization in diabetics, which is defined clinically as insulin resistance which promotes obesity.
“On the one hand, insulin loses the function to enhance cellular glucose uptake and utilization in diabetics, which is defined clinically as insulin resistance which promotes obesity.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAging and obesity are two risk factors of diabetes.
“Moreover, aging and obesity are two risk factors of diabetes as well. A variety of studies have the consensus that aging as well as obesity have positive associations with diabetes.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationDue to the chronic progress of sarcopenic obesity, symptoms hardly draw attention, resulting in poor diagnosis, which causes negative consequences of quality of life and all-cause mortality.
“Due to the chronic progress of SO, the symptoms hardly draw people's attention, resulting in poor diagnosis, which causes negative consequences of quality of life and all-cause mortality (8).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] Stephen, 2009, Sarcopenic-obesity and cardiovascular disease risk in the elderly, J Nutr Health Aging. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Interpretationnone givenSarcopenic obesity and diabetes are two increasing health problems worldwide, and both share many common risk factors, such as aging and general obesity.
“Sarcopenic obesity and diabetes are two increasing health problems worldwide, which both share many common risk factors, such as aging, and general obesity.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisereasoningSarcopenic obesity occurs in the old without increase of body weight, which could be due to the ectopic redistribution of fat.
“However, it is also common that SO occurs in the old without increase of body weight, which could be due to the ectopic redistribution of fat.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationElevated levels of IL-6 and C-reactive protein (CRP) are related to sarcopenic obesity, which in turn have suppressive effects on muscle strength.
“A study conducted in Italy has verified that elevated levels of IL-6 and C-reactive protein (CRP) are related to SO, which in turn have suppressive effects on muscle strength (26).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [26] Schrager, 2007, Sarcopenic obesity and inflammation in the InCHIANTI study, J Appl Physiol source
Not checked in the free run.
May combine two claims.
PremisereasoningWith aging, the reduction of basal metabolic rates may lead to weight gain and muscle mass decrease, which are associated with sarcopenic obesity.
“With aging, the reduction of basal metabolic rates may lead to weight gain and muscle mass decrease, which are associated with SO.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationFat tends to move to viscera, muscle and abdomen with age, and ectopic fat causes disorders of inflammatory factors, insulin and hormones, thus resulting in sarcopenic obesity.
“Studies have found that fat tends to move to viscera, muscle and abdomen with age, and the ectopic fat cause disorders of inflammatory factors, insulin and hormones, thus resulting in SO (15).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [15] Polyzos, 2018, Sarcopenic obesity, Hormones. source
Not checked in the free run.
May combine two claims.
PremisecitationMyostatin inhibits muscle cell growth and differentiation, and irisin stimulates the increase of muscle mass.
“It is believed that myostatin inhibits muscle cell growth and differentiation, and irisin stimulates the increase of muscle mass (42, 43).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationObesity is related to a low-grade inflammation, and increased production and secretion of inflammatory factors including TNF-α and IL-6 modulate insulin sensitivity by altering key steps in the insulin signaling pathway, which is responsible for subsequent insulin resistance.
“Meanwhile, obesity is related to a low-grade inflammation, the increased production and secretion of multifarious inflammatory factors including TNF-α, IL-6 modulate insulin sensitivity by altering some key steps in the insulin signaling pathway, which is responsible for the subsequent insulin resistance (34–36).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [34] Mcternan, 2006, Recent advances in the relationship between obesity, inflammation, insulin resistance, Eur Cytokine Netw. source
Not checked in the free run.
- cites [35] Shoelson, 2007, Inflammation, insulin resistance, Gastroenterology. source
Not checked in the free run.
- cites [36] Matulewicz, 2016, Insulin resistance and chronic inflammation, Postepy Hig Med Dosw. source
Not checked in the free run.
May combine two claims.
PremisecitationThe content of myostatin is upregulated while irisin is downregulated in sarcopenia.
“However, several studies have documented that the content of myostatin is upregulated while irisin is downregulated in sarcopenia (44).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [44] Chang, 2017, Circulating irisin levels as a predictive biomarker for sarcopenia: a cross-sectional community-based study, Geriatr Gerontol Int source
Not checked in the free run.
May combine two claims.
Premisenone givenOld people tend to decrease physical activity, which contributes to the severe loss of muscle strength.
“In fact, old people tend to decrease physical activity, which contributes to the severe loss of muscle strength.”
Quote in the paperSubstantial claimMay combine two claims.
PremisereasoningAtrophic muscles make it even more difficult for elderly people to exercise, further aggravating the sedentary lifestyle.
“Then atrophic muscles make even more difficult for elderly people to exercise, further aggravating the sedentary lifestyle.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationnone givenMultiple factors cause sarcopenic obesity, such as aging, lack of physical activity, malnutrition, low-grade inflammation, insulin resistance, and hormonal changes, which lead to body composition changes (muscle mass and strength decline and fat mass increase).
“There are multiple factors that cause sarcopenic obesity, such as aging, lack of physical activity, malnutrition low-grade inflammation, insulin resistance and hormonal changes, which leads to body composition changes (muscle mass and strength decline and fat mass increase).”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationDysfunctional insulin production occurs, gradually leading to insulin resistance.
“Thereby, dysfunctional insulin production occurs, gradually leading to insulin resistance (28).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [28] Michio, 2017, Leptin resistance and lipolysis of white adipose tissue: an implication to ectopic fat disposition and its consequences, J Atheroscler Thromb. source
Not checked in the free run.
May combine two claims.
PremisecitationPhysical activity is necessary to lose weight and improve muscle strength, which is beneficial to ameliorate the state of sarcopenic obesity.
“Numerous studies have proven that physical activity is necessary to lose weight and improve muscle strength, which is beneficial to ameliorate the state of SO (16, 17).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [16] Patel, 2018, Marrow adiposity and hematopoiesis in aging and obesity: exercise as an intervention, Curr Osteoporos Rep. source
Not checked in the free run.
- cites [17] Pedersen, 2012, Muscles, exercise and obesity: skeletal muscle as a secretory organ, Nat Rev Endocrinol. source
Not checked in the free run.
May combine two claims.
PremisecitationEither low-grade inflammation or ectopic fat distribution generates myokine imbalance and mitochondrial dysfunction.
“Moreover, either low-grade inflammation or ectopic fat distribution generates myokine imbalance and mitochondrial dysfunction (32, 33).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [32] Goya, 2015, Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity, Proc Nutr Soc. source
Not checked in the free run.
- cites [33] Kalinkovich, 2017, Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis, Ageing Res Rev. source
Not checked in the free run.
May combine two claims.
PremisecitationA down-regulation of genes involving mitochondrial enzymes declines mitochondrial content, which has been found in insulin resistant states, augmenting accumulation of fat in muscle and liver.
“A down-regulation of genes involving mitochondrial enzymes declines mitochondrial content, which has been found in insulin resistant states (39, 40), augmenting accumulation of fat in muscle and liver.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [39] Mootha, 2003, PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nat Genet. source
Not checked in the free run.
- cites [40] Patti, 2003, Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1, Proc Natl Acad Sci USA. source
Not checked in the free run.
May combine two claims.
PremisecitationInsulin resistance is essential for protein anabolism, thus directly concerns muscle fiber atrophy.
“Studies have elucidated that insulin resistance is essential for protein anabolism, thus directly concerns muscle fiber atrophy (37).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [37] Nomura, 2007, Muscle strength is a marker of insulin resistance in patients with type 2 diabetes: a pilot study, Endocr J. source
Not checked in the free run.
May combine two claims.
PremisecitationThe highest level of monocyte chemoattractant protein-1 (MCP-1) and the lowest level of appendicular lean mass are found in the sarcopenic obesity group.
“The study has found the highest level of monocyte chemoattractant protein-1 (MCP-1) and the lowest level of appendicular lean mass in SO group (27), which supports the theory that low-grade inflammation is linked to SO.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [27] Lim, 2015, Monocyte chemoattractant protein-1: a proinflammatory cytokine elevated in sarcopenic obesity, Clin Intervent Aging. source
Not checked in the free run.
May combine two claims.
Premisenone givenThe production and efficiency of insulin decline in elderly and obese people.
“The production and efficiency of insulin decline in elderly and obese people.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningWeight generally increases in elderly people.
“Therefore, weight generally increases in elderly people.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenIncreased level of leptin contributes to leptin resistance, resulting in accumulation of free fatty acids.
“Besides, the increased level of leptin contributes to leptin resistance, resulting in accumulation of free fatty acids.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe amount of bone mass and muscle mass peaks around 30 years old, and after that, a gradual loss of muscle mass is accompanied with a parallel gain of fat mass.
“Meanwhile, studies have validated that the amount of bone mass and muscle mass peak around 30 years old, and after that, a gradual loss of muscle mass is accompanied with a parallel gain of fat mass (14).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Mourtzakis, 2008, A practical and precise approach to quantifica- tion of body composition in cancer patients using computed tomog- raphy images acquired during routine care, Appl Physiol Nutr Metab source
Not checked in the free run.
May combine two claims.
PremisecitationAdipocytes promote macrophage recruitment, then adipocytes and immune cells secrete more adipokines such as leptin, chemerin, resistin, and more cytokines such as TNF-α, ILs, INF-γ, creating a circumstance of low-grade inflammation.
“Specifically, adipocytes promote macrophage recruitment (21), then adipocytes and immune cells secrete more adipokines such as leptin, chemerin, resistin, and more cytokines such as tumor necrosis factor-α (TNF-α), interleukins (ILs), interferon-γ (INF-γ) (22–25), creating a circumstance of low-grade inflammation.”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [21] Neels, 2005, Inflamed fat: what starts the fire?, J Clin Invest. source
Not checked in the free run.
- cites [22] Polyzos, 2016, Adipose tissue, obesity and nonalcoholic fatty liver disease, Minerva Endocrinologica. source
Not checked in the free run.
- cites [23] Kim, 2013, Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean sarcopenic obesity study, Clin Endocrinol. source
Not checked in the free run.
- cites [24] Dong, 2019, Molecular dynamics of the recruitment of immunoreceptor signaling module DAP12 homodimer to lipid raft boundary regulated by PIP2, J Phys Chem B. source
Not checked in the free run.
- cites [25] Wei, 2017, Critical residues and motifs for homodimerization of the first transmembrane domain of the plasma membrane glycoprotein CD36, J Biol Chem. source
Not checked in the free run.
May combine two claims.
PremisecitationMitochondrial dysfunction causes more lipid peroxidation, which reinforces the collections of lipid intermediates and reactive oxygen metabolites, accelerating inflammation, insulin resistance, and oxidative stress.
“Also, mitochondrial dysfunction causes more lipid peroxidation, which reinforces the collections of lipid intermediates and reactive oxygen metabolites, accelerating inflammation, insulin resistance, and oxidative stress (33).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] Kalinkovich, 2017, Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis, Ageing Res Rev. source
Not checked in the free run.
May combine two claims.
PremisecitationThe increase in myostatin and decrease in irisin are tightly associated with poor browning reaction of white fat, reducing energy expenditure, triggering fat gain.
“At the same time, the increase in myostatin and decrease in irisin are tightly associated with poor browning reaction of white fat, reducing energy expenditure, triggering fat gain (45).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [45] Colaianni, 2017, Irisin and musculoskeletal health, Ann N Y Acad Sci. source
Not checked in the free run.
May combine two claims.
Premisenone givenBoth aging and physical inactivity contribute to weight gain, by which an increase in adipose cell size may be determined.
“Both aging and physical inactivity have contributions on weight gain, by which an increase in adipose cell size may be determined.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Interpretationnone givenEach factor has independent impacts on the quality and quantity of muscle and fat, whereas the cross-talks of them have stronger influences.
“Moreover, each factor has independent impacts on the quality and quantity of muscle and fat, whereas, the cross-talks of them have stronger influences.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationObese individuals with insulin resistance have a higher rate of muscle catabolism, evidenced by a study that leg muscle strength and quality decrease distinctly in older diabetics.
“Obese individuals with insulin resistance have a higher rate of muscle catabolism, which has been evidenced in a study that leg muscle strength and quality decrease distinctly in older diabetics (38).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [38] Abbatecola, 2005, Insulin resistance and muscle strength in older persons, J Gerontol. source
Not checked in the free run.
May combine two claims.
PremisecitationTestosterone and estrogen are essential for muscle health, but the production of these hormones decline naturally with aging.
“Moreover, testosterone and estrogen are essential for muscle health (47), but the production of these hormones decline naturally with aging.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [47] Choi, 2013, Sarcopenia and sarcopenic obesity, Endocrinol Metab (Seoul). source
Not checked in the free run.
May combine two claims.
PremisecitationThe inner mitochondrial membrane of islet β cells fails to protect, which increases the permeability of mitochondrial membrane, leading to β cells apoptosis.
“Thus, the inner mitochondrial membrane of islet β cells fails to protect, which increases the permeability of mitochondrial membrane, leading to β cells apoptosis (75, 76).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [75] Nolan, 2014, Lipotoxicity, β cell dysfunction, gestational diabetes, Cell Metab. source
Not checked in the free run.
- cites [76] Farrell, 2018, Pathogenesis of NASH: how metabolic complications of overnutrition favour lipotoxicity and pro-inflammatory fatty liver disease, Adv Exp Med Biol. source
Not checked in the free run.
May combine two claims.
PremisecitationCompared to non-sarcopenic-obesity participants, subjects with sarcopenic obesity have a 24% increased risk of all-cause mortality, especially in men.
“A meta-analysis of 12 prospective cohort studies has indicated that compare to non-SO participants, subjects with SO have a 24% increased risk of all-cause mortality, especially in men.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [52] Tian, 2016, Association of sarcopenic obesity with the risk of all-cause mortality: a meta-analysis of prospective cohort studies, Geriatr Gerontol Int. source
Not checked in the free run.
May combine two claims.
PremisecitationPersistent elevated levels of glucose can swamp the glycolytic process and inhibit glyceraldehyde catabolism, which promotes reactive oxygen species (ROS) production and oxidative damage, inducing β cells apoptosis and inhibiting β cells secretion.
“Persistent elevated levels of glucose can swamp the glycolytic process and inhibit glyceraldehyde catabolism, which promotes reactive oxygen species (ROS) production and oxidative damage, inducing β cells apoptosis and inhibiting β cells secretion (73, 74).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
Premisenone givenEither low muscle mass and strength or obesity is an independent risk factor for reduced physical capacity and quality of life.
“It is acknowledged that either low muscle mass and strength or obesity is an independent risk factor for reduced physical capacity and quality of life.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationLoss of muscle mass and strength makes a higher risk of osteoarthritis, which exacerbates physical inactivity, worsening both physical and mental health.
“As the loss of muscle mass and strength makes a higher risk of osteoarthritis (63, 64), this exacerbates physical inactivity, worsening both physical and mental health.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [63] Lee, 2012, Sarcopenic obesity is more closely associated with knee osteoarthritis than is nonsarcopenic obesity: a cross-sectional study, Arthritis Rheum. source
Not checked in the free run.
- cites [64] Misra, 2019, Risk of knee osteoarthritis with obesity, sarcopenic obesity, and sarcopenia, Arthritis Rheumatol. source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationWhen muscle damage and obesity coexist, they act synergistically on the risk of mortality, metabolic disorders, and quality of life.
“Therefore, it is reasonable to speculate when muscle damage and obesity coexist, they act synergistically on the risk of mortality, metabolic disorders, and quality of life (47, 51).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationThe reduction of IGF-1 is accompanied by the downregulation of irisin, and high level of free fatty acids in obese people inhibits both IGF-1 and growth hormone, which lowers the mass and strength of muscle, leading to muscle impairment and thus to sarcopenic obesity.
“The reduction of IGF-1 is accompanied by the downregulation of irisin (45), and high level of free fatty acids in obese people inhibits both IGF-1 and growth hormone (48), which lowers the mass and strength of muscle, leading to muscle impairment and thus to SO (49).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [45] Colaianni, 2017, Irisin and musculoskeletal health, Ann N Y Acad Sci. source
Not checked in the free run.
- cites [48] Weltman, 2001, Body composition, physical exercise, growth hormone and obesity, Eat Weight Disord.
Not checked in the free run.
- cites [49] Waters, 2008, Altered growth hormone, cortisol, and leptin secretion in healthy elderly persons with sarcopenia and mixed body composition phenotypes, J Gerontol. source
Not checked in the free run.
May combine two claims.
PremisecitationImpaired insulin secretion is multifactorial, the exact mechanism is still unclear, but commonly develops from glucose toxicity, lipid toxicity, immunoinflammatory response, and oxidative stress, leading to the dysfunction of islet β cells.
“Impaired insulin secretion is multifactorial, the exact mechanism is still unclear, but commonly develops from glucose toxicity, lipid toxicity, immunoinflammatory response, and oxidative stress, leading to the dysfunction of islet β cells (72).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [72] Zhang, 2018, Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link, Behav Brain Res. source
Not checked in the free run.
May combine two claims.
PremisecitationThe highest fall risk and the lowest muscle function test results are in the sarcopenic obesity group, confirming an inverse association with health-related quality of life scores.
“Therefore, these factors, which significantly affect the quality of life for elderly people, have been illustrated in another study that the highest fall risk and the lowest muscle function test results in the SO group, confirming an inverse association with health-related quality of life scores (66).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [66] Öztürk, 2018, Health-related quality of life and fall risk associated with age-related body composition changes; sarcopenia, obesity and sarcopenic obesity, Inter Med J. source
Not checked in the free run.
May combine two claims.
PremisecitationIn a Japanese study, all-cause mortality increases in men with sarcopenic obesity defined by waist circumference (HR, 1.19; 95% CI, 1.02-1.38), but not body mass index (BMI) or percent body fat (BF%).
“Moreover, in a Japanese study, all-cause mortality increases in men with SO defined by waist circumference (HR, 1.19; 95% CI, 1.02–1.38), but not body mass index (BMI) or percent body fat (BF%) (53).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [53] Sanada, 2017, Association of sarcopenic obesity predicted by anthropometric measurements and twenty-four year all-cause mortality in elderly men: the kuakini honolulu heart program, Nutrition. source
Not checked in the free run.
May combine two claims.
PremisecitationProlonged as well as elevated levels of glucose blood, high free fatty acids, and chronic inflammatory environment, all increase the levels of ROS, activating the mechanism of oxidative stress.
“As mentioned above, prolonged as well as elevated levels of glucose blood, high free fatty acids, and chronic inflammatory environment, all increase the levels of ROS, activating the mechanism of oxidative stress (81).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [81] Rendra, 2019, Reactive oxygen species (ROS) in macrophage activation and function in diabetes, Immunobiology. source
Not checked in the free run.
May combine two claims.
PremisecitationBoth obesity and hyperglycemia promote the release of inflammatory mediators, like TNF-α or IL-6, and released mediators stimulate macrophages and other innate immune cells, as well as some apoptosis-related signaling pathways, such as Fas/FasL signaling pathway.
“Both obesity and hyperglycemia promote the release of inflammatory mediators, like TNF-α, or IL-6, released mediators stimulate macrophages and other innate immune cells, as well as some apoptosis-related signaling pathways, such as Fas/FasL signaling pathway (78, 79).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationChronic inflammatory environment is also beneficial for the formation of free radicals such as reactive oxygen species (ROS), exacerbating β cells damage and yielding a positive feedback circle with the secretion of more detrimental cytokines to trigger further damage to β cells.
“Besides, chronic inflammatory environment is also beneficial for the formation of free radicals such as reactive oxygen species (ROS), exacerbating β cells damage and yielding a positive feedback circle with the secretion of more detrimental cytokines to trigger further damage to β cells (80).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [80] Blaser, 2016, TNF and ROS crosstalk in inflammation, Trends Cell Biol. source
Not checked in the free run.
May combine two claims.
PremisecitationROS is capable to directly damage β cells, promoting apoptosis, or it can indirectly regulate insulin signaling pathway to inhibit the function of β cells.
“Therefore, ROS is capable to directly damage β cells, promoting apoptosis, or it can indirectly regulate insulin signaling pathway to inhibit the function of β cells (82, 83).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [82] Robertson, 2004, Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes, J Biol Chem. source
Not checked in the free run.
- cites [83] Panigrahy, 2017, Reactive oxygen species: sources, consequences and targeted therapy in type 2 diabetes, J Drug Target. source
Not checked in the free run.
May combine two claims.
PremisecitationStudies have estimated 10-years risk of cardiovascular disease in the sarcopenic obesity group, non-sarcopenic group, and non-obese group, and a significant increase has been found in the sarcopenic obesity group.
“In addition, studies have also estimated 10-years risk of CVD in SO group, non-sarcopenic group, and non-obese group, and a significant increase has been found in the SO group (58).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [58] Jeong-Hyeon, 2015, Relationship between sarcopenic obesity and cardiovascular disease risk as estimated by the framingham risk score, J Korean Med Sci. source
Not checked in the free run.
May combine two claims.
PremisecitationIndividuals with sarcopenic obesity are associated with increased waist circumference, elevated fasting blood glucose, insulin resistance, higher blood pressure, and abnormal blood lipids as compared to sarcopenia or obesity alone.
“Several Korean studies have indicated that individuals with SO are associated with increased waist circumference, elevated fasting blood glucose, insulin resistance, higher blood pressure, and abnormal blood lipids as compared to sarcopenia or obesity alone (13, 23, 56).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [13] Baek, 2014, Sarcopenia and sarcopenic obesity and their association with dyslipidemia in Korean elderly men: the 2008–2010 Korea National health and nutrition examination survey, J Endocrinol Invest. source
Not checked in the free run.
- cites [23] Kim, 2013, Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean sarcopenic obesity study, Clin Endocrinol. source
Not checked in the free run.
- cites [56] Kim, 2009, Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study, Int J Obes (Lond). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationDiabetes is considered as an independent risk factor for coronary heart diseases.
“Moreover, recent studies have shown that diabetes is considered as an independent risk factor for coronary heart diseases (114).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [114] Leon, 2015, Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research, World J Diabetes. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThere is 1-2% of diabetic patients who will develop pancreatic cancer in 3 years.
“It has been proven that there is 1–2% of diabetic patients who will develop pancreatic cancer in 3 years (118).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [118] Magruder, 2016, Diabetes and pancreatic cancer: chicken or egg? source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIndividuals with diabetes suffer from a higher risk of cardiovascular diseases compared to those without diabetes, which is associated with a number of common risk factors such as age, obesity, smoking, hypertension, and dyslipidemia.
“Individuals with diabetes suffer from a higher risk of cardiovascular diseases compared to those without diabetes, which is associated with a number of common risk factors such as age, obesity, smoking, hypertension, and dyslipidemia (113).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [113] de Matheus, 2013, Impact of diabetes on cardiovascular disease: an update, Int J Hypertens. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationGSK3β is one of the few protein kinases of which the activity can be inhibited by phosphorylation.
“GSK3β is one of the few protein kinases of which the activity can be inhibited by phosphorylation (94).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [94] Yaribeygi, 2019, Insulin resistance: review of the underlying molecular mechanisms, J Cell Physiol. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationNeuropathy is associated with a 1.7-fold increase in the risk of amputation, and even higher when coupled with other problems.
“It has been reported that neuropathy is associated with a 1.7-fold increase in the risk of amputation, and even higher when coupled with other problems (107).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [107] Vinik, 2013, Diabetic neuropathy, Endocrinol Metab Clin North Am. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationRecent studies have regarded Alzheimer's disease as type 3 diabetes because of insulin signaling pathways damage.
“Recent studies have regarded Alzheimer's disease as type 3 diabetes because of insulin signaling pathways damage (123).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [123] Kandimalla, 2017, Is alzheimer's disease a type 3 diabetes? a critical appraisal, Biochim Biophys Acta Mol Basis Dis. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSexual dysfunction becomes more and more popular in both men and women with diabetes.
“Moreover, sexual dysfunction becomes more and more popular in both men and women with diabetes (124).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [124] Bak, 2017, Relationships of sexual dysfunction with depression and acceptance of illness in women and men with type 2 diabetes mellitus, Int J Environ Res Public Health. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPatients with type 2 diabetes in Asian countries have a lower risk of coronary diseases than those from eastern Europe or Established Market Economies.
“Interestingly, a study has indicated that patients with T2D in Asian countries have a lower risk of coronary diseases than those from eastern Europe or Established Market Economies (100).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [100] Clarke, 2010, Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis, PLoS Med. source
Not checked in the free run.
May combine two claims.
PremisecitationWhen the insulin signaling pathway fails, the expression of GSK3β improves, which reduces the insulin sensitivity and increases the levels of blood glucose, thus subsequently leading to type 2 diabetes.
“When the insulin signaling pathway fails, the expression of GSK3β improves, which reduces the insulin sensitivity and increases the levels of blood glucose, thus subsequently leading to T2D (72, 96, 97).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [72] Zhang, 2018, Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link, Behav Brain Res. source
Not checked in the free run.
- cites [96] Arneth, 2019, Metabolomics of type 1 and type 2 diabetes, Int J Mol Sci. source
Not checked in the free run.
- cites [97] Gao, 2011, GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease, Rev Neurosci. source
Not checked in the free run.
May combine two claims.
PremisecitationDiabetes contributes a 27% increased risk of breast cancer in women and predisposes to more aggressive cancer stages.
“Moreover, diabetes contributes a 27% increased risk of breast cancer in women and predisposes to more aggressive cancer stages (120).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [120] Boyle, 2012, Diabetes and breast cancer risk: a meta-analysis, Br J Cancer. source
Not checked in the free run.
May combine two claims.
PremisecitationDiabetes serves as an independent risk factor for colorectal cancer; there is a 49% increased risk of colorectal cancer in men with diabetes.
“Also, diabetes serves as an independent risk factor for colorectal cancer as a study has found that there is a 49% increased risk of colorectal cancer in men with diabetes (119).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [119] Larsson, 2005, Diabetes and colorectal cancer incidence in the cohort of Swedish men, Diabetes Care. source
Not checked in the free run.
May combine two claims.
PremisecitationHigh prevalence of depression as one of psychological complications that result from diabetes, makes it harder for diabetics to manage blood glucose, thus leading to further complications.
“Besides, high prevalence of depression as one of psychological complications that result from diabetes, makes it harder for diabetics to manage blood glucose, thus leading to further complications (125).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [125] Semenkovich, 2015, Depression in type 2 diabetes mellitus: prevalence, impact, and treatment, Drugs. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationDiabetic neuropathy involves various syndromes, such as mono- and polyneuropathies, plexopathies, radiculopathies and autonomic neuropathy, among which distal symmetric polyneuropathy is very prevalent.
“Diabetic neuropathy involves various syndromes, such as mono- and polyneuropathies, plexopathies, radiculopathies and autonomic neuropathy, among which distal symmetric polyneuropathy is very prevalent (108).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [108] Feldman, 2019, Diabetic neuropathy, Nat Rev Dis Primers. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenOne of the structural changes in diabetic retinopathy is widened retinal arteriolar caliber which might be an early sign of microvascular dysfunction.
“One of the structural changes in diabetic retinopathy is widened retinal arteriolar caliber which might be an early sign of microvascular dysfunction.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe true prevalence of diabetic neuropathy is unclear but it varies from 10 to 90% in diabetics, according to the different standards and approaches used to define diabetic neuropathy.
“The true prevalence is unclear but it varies from 10 to 90% in diabetics, according to the different standards and approaches used to define diabetic neuropathy (107).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [107] Vinik, 2013, Diabetic neuropathy, Endocrinol Metab Clin North Am. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenDiabetic neuropathy is one of the most prominent complications of diabetes.
“Diabetic neuropathy is one of the most prominent complications of diabetes.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAnother change is widened retinal venular caliber which might be independently related to the prevalence and progression in diabetic retinopathy, as well as an indicator of developing retinopathy.
“Also, another change is widened retinal venular caliber which might be independently related to the prevalence and progression in diabetic retinopathy, as well as an indicator of developing retinopathy (105, 106).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [105] Cheung, 2010, Diabetic retinopathy, Lancet. source
Not checked in the free run.
- cites [106] Sosna, 2016, History of diagnosis and therapy of diabetic retinopathy, Vnitr Lek.
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenUnmanaged diabetes can cause multiple complications, most common of which are microvascular complications: nephropathy, retinopathy, and neuropathy, and macrovascular complications: cardiovascular diseases.
“Unmanaged diabetes can cause multiple complications, most common of which are microvascular complications: nephropathy, retinopathy, and neuropathy, and macrovascular complications: cardiovascular diseases.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCancer is a class of diseases resulted from external factors such as environment, diet and radiation as well as internal factors including obesity and diabetes.
“Cancer is a class of diseases resulted from external factors such as environment, diet and radiation as well as internal factors including obesity and diabetes (31, 116, 117).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [31] Liao, 2019, Reactive oxygen species: a volatile driver of field cancerization and metastasis, Mol Cancer. source
Not checked in the free run.
- cites [116] Yang, 2019, Concentrated ambient PM2. 5 exposure affects mice sperm quality and testosterone biosynthesis, PeerJ. source
Not checked in the free run.
- cites [117] Stone, 2018, Obesity and cancer: existing and new hypotheses for a causal connection, EBioMedicine. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThere are many diabetes-related ocular diseases, such as cataract, glaucoma, ischemic optic neuropathy, cranial nerve palsies, and recurrent corneal erosion syndrome.
“There are many diabetes-related ocular diseases, such as cataract, glaucoma, ischemic optic neuropathy, cranial nerve palsies, and recurrent corneal erosion syndrome (102).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [102] Henriques, 2015, Diabetic eye disease, Acta Med Port. source
Not checked in the free run.
May combine two claims.
Premisenone givenThe transduction of the insulin PI3K/AKT signaling pathway is weakened, which may be the major manifestation of insulin resistance, impacting the downstream mediator-glycogen synthase kinase-3β (GSK3β).
“Meanwhile, the transduction of the insulin PI3K/AKT signaling pathway is weakened, which may be the major manifestation of insulin resistance, impacting the downstream mediator—glycogen synthase kinase-3β (GSK3β).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationWith the destruction of β cells, the peak of insulin secretion will be delayed, intensifying the fluctuation of blood glucose, resulting in further severe damage of β cells.
“With the destruction of β cells, the peak of insulin secretion will be delayed, intensifying the fluctuation of blood glucose, resulting in further severe damage of β cells (85).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [85] Newsholme, 2016, Molecular mechanisms of ROS production and oxidative stress in diabetes, Biochem J. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe risk of diabetic kidney disease is much higher in Asian countries than in Western countries due to different economic outcomes.
“A study has found that the risk of diabetic kidney disease is much higher in Asian countries than in Western countries due to different economic outcomes (100).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [100] Clarke, 2010, Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis, PLoS Med. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCardiovascular diseases, involving coronary heart disease, peripheral vascular disease and cerebrovascular disease, are the primary contributors of death and disability in diabetic people.
“Cardiovascular diseases, involving coronary heart disease, peripheral vascular disease and cerebrovascular disease, are the primary contributors of death and disability in diabetic people (112).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [112] Henning, 2018, Type-2 diabetes mellitus and cardiovascular disease, Future Cardiol. source
Not checked in the free run.
May combine two claims.
PremisecitationA vegetarian diet demonstrated better weight loss and insulin sensitivity.
“The macrobiotic and vegan diets were beneficial to glycemic control, while the vegetarian diet demonstrated better weight loss and insulin sensitivity.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [159] Papamichou, 2019, Dietary patterns and management of type 2 diabetes: a systematic review of randomised clinical trials, Nutr Metab Cardiovasc Dis. source
Not checked in the free run.
May combine two claims.
PremisecitationThe benefits of Mediterranean diets were greater than low-fat diets in diabetic retinopathy, but no significant differences were found in diabetic nephropathy.
“In addition, a study has also found that the benefits of Mediterranean diets were greater than low-fat diets in diabetic retinopathy, but no significant differences were found in diabetic nephropathy (160).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [160] Díaz-López, 2015, Mediterranean diet, retinopathy, nephropathy, and microvascular diabetes complications: a post hoc analysis of a randomized trial, Diabetes Care. source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisereasoningDXA is recommended to estimate the lean and fat mass of the whole body or certain regions of body.
“Therefore, another relatively inexpensive and low radiation method called dual-energy-X-ray absorptiometry (DXA) is recommended to estimate the lean and fat mass of the whole body or certain regions of body.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationEven caloric restriction might cause loss of muscle mass, but it is still more beneficial to mobility and strength when accompanied by resistance training.
“Moreover, another study has demonstrated that even caloric restriction might cause loss of muscle mass, and hence, it is still more beneficial to mobility and strength when accompanying with resistance training (148).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [148] Nicklas, 2015, Effects of resistance training with and without caloric restriction on physical function and mobility in overweight and obese older adults: a randomized controlled trial, Am J Clin Nutr. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenKnee flexion/extension is strongly related with certain functional activities.
“Furthermore, keen flexion/extension is strongly related with certain functional activities.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationDXA manifests strength in assessment of bone mass and density, thus simultaneously providing the conditions of bone, muscle, and fat.
“Moreover, it also manifests strength in assessment of bone mass and density, thus simultaneously providing the conditions of bone, muscle, and fat (130, 131).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [130] Ilich, 2016, Osteosarcopenic obesity syndrome: what is it and how can it be identified and diagnosed?, Curr Gerontol Geriatr Res. source
Not checked in the free run.
- cites [131] Berger-Groch, 2020, Assessment of bone quality at the lumbar and sacral spine using CT scans: a retrospective feasibility study in 50 comparing CT and DXA data, Eur Spine J. source
Not checked in the free run.
May combine two claims.
PremisecitationPhysical activity has multiple biological effects: promoting insulin sensitivity, improving anabolic response to endogenous amino acids, activating skeletal muscle satellite cells and triggering their proliferation and differentiation, amplifying irisin production, adjusting hormonal milieu, increasing mitochondrial biogenesis, ameliorating inflammation, and reducing oxidative stress.
“Indeed, there are multiple biological effects of physical activity: promote insulin sensitivity, improve anabolic response to endogenous amino acids, activate skeletal muscle satellites cells and trigger the proliferation and differentiation of them, amplify irisin production, adjust hormonal milieu, increase mitochondrial biogenesis, ameliorate inflammation and reduce oxidative stress (162–164).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [162] Barazzoni, 2018, Sarcopenic obesity: time to meet the challenge, Obesity Facts. source
Not checked in the free run.
- cites [163] Joseph, 2016, Beneficial effects of exercise on age-related mitochondrial dysfunction and oxidative stress in skeletal muscle, J Physiol. source
Not checked in the free run.
- cites [164] Mooren, 2015, Exercise autophagy, and apoptosis, Prog Mol Biol Transl Sci. source
Not checked in the free run.
May combine two claims.
PremisecitationOlder people have anabolic resistance, so a higher protein intake is needed to promote muscle protein synthesis.
“While in older people, a higher protein intake should be provided in order to promote muscle protein synthesis due to anabolic resistance.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [149] Deutz, 2014, Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group, Clin Nutr. source
Not checked in the free run.
- cites [150] Bauer, 2013, Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group, J Am Med Direct Assoc. source
Not checked in the free run.
- cites [151] Paddon-Jones, 2009, Dietary protein recommendations and the prevention of sarcopenia, Curr Opin Cin Nutr Metab Care. source
Not checked in the free run.
May combine two claims.
PremisecitationA high-protein diet improves muscle strength in sarcopenic obesity patients and prevents weight loss-induced sarcopenia.
“A similar result has been shown in another study that high-protein diet improves muscle strength in SO patients and prevent weight loss-induced sarcopenia (152).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [152] Sammarco, 2017, Evaluation of hypocaloric diet with protein supplementation in middle-aged sarcopenic obese women: a pilot study, Obesity Facts. source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Premisenone givenHandgrip strength is a great predictor of extremity muscle power and mobility.
“Handgrip strength is a great predictor of extremity muscle power and mobility.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe American Diabetes Association recognizes four approaches to diagnose diabetes: fasting plasma glucose test, two-hour oral glucose tolerance test, glycated hemoglobin, and random plasma glucose coupled with symptoms.
“According to American Diabetes Association (ADA), there are four approaches to diagnosis diabetes: Fasting plasma glucose test (FPG), Two-Hour Oral Glucose Tolerance Test (OGTT), Glycated Hemoglobin (A1C), and Random plasma glucose coupled with symptoms (67).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [67] 2015, (2) Classification and diagnosis of diabetes, Diabetes Care. source
Not checked in the free run.
May combine two claims.
PremisecitationA1C reflects average blood glucose over the last 2-3 months and is relatively accurate because it is less influenced by acute illness or stress.
“A1C shows the average of blood glucose over last 2–3 months, and it is relative accurate since less influence by acute illness or stress.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [67] 2015, (2) Classification and diagnosis of diabetes, Diabetes Care. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationBIA is used to measure muscle mass, but the inaccuracy makes it unrecommended to diagnose sarcopenia.
“In addition, as an affordable and available tool, bioelectrical impedance analysis (BIA) is used to measure muscle mass as well, whereas, the inaccuracy makes it unrecommended to diagnose sarcopenia (132).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [132] Bosy-Westphal, 2017, Quantification of whole-body and segmental skeletal muscle mass using phase-sensitive 8-electrode medical bioelectrical impedance devices, Eur J Clin Nutr source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe diagnosis of sarcopenic obesity varies with the changes of the diagnosis of obesity and sarcopenia.
“However, the diagnosis of SO varies with the changes of the diagnosis of obesity and sarcopenia.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIt is hard to generalize CT and MRI due to the high cost, and the risk of radiation (for CT).
“However, it is hard to generalize CT and MRI due to the high cost, and the risk of radiation (for CT) (129).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [129] Donini, 2020, Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review, Clin Nutr. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMany professional organizations recommend that a combination of resistance training and aerobic training is the most practical way to improve physical performance.
“many professional organizations recommend that a combination of resistance training and aerobic training seems to be the most practical way to improve physical performance (165, 166).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [165] Lombardo, 2019, Sarcopenic obesity: etiology and lifestyle therapy, Eur Rev Med Pharmacol Sci. source
Not checked in the free run.
- cites [166] Batsis, 2018, Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies, Nat Rev Endocrinol. source
Not checked in the free run.
May combine two claims.
PremisecitationVitamin D deficiency is associated with lower muscle strength, greater body instability, falls, and disability in the geriatric population.
“several studies have suggested that vitamin D deficiency is associated with lower muscle strength, greater body instability, falls and disability in geriatric population (153).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [153] Bellia, 2013, Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects, Inter Emerg Med. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenPeak expiratory flow manifests the strength of respiratory muscles, but it is not considered as a separated method.
“Although peak expiratory flow manifests the strength of respiratory muscles, it is not considered as a separated method.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationMajor RCTs in non-sarcopenic women with obesity suggest that caloric restriction with a 500 kcal deficit and at least 0.8 g/kg protein intake can effectively lose fat and improve physical function.
“Major RCTs in non-sarcopenic women with obesity have suggested that caloric restriction (500 kcal deficit) with at least 0.8 g/kg of protein intake can effectively lose fat and improve physical function (146, 147).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [146] Backx, 2016, Protein intake and lean body mass preservation during energy intake restriction in overweight older adults, Int J Obesity. source
Not checked in the free run.
- cites [147] Petroni, 2019, Prevention and treatment of sarcopenic obesity in women, Nutrients. source
Not checked in the free run.
May combine two claims.
Premisenone givenCT and MRI are deemed as the gold standard to distinguish fat from other soft tissues, thereby effectively estimating fat mass and muscle mass.
“Various techniques emerge for assessing muscle mass, among which, computed tomography (CT) and magnetic resonance imaging (MRI) are deemed as the gold standard to distinguish fat from other soft tissues, thereby, effectively estimating fat mass and muscle mass.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationVegan, vegetarian, and Mediterranean diets are better strategies to control glycemic markers in diabetics.
“Therefore, the study has concluded that vegan, vegetarian and Mediterranean diets are better strategies to control glycemic marker in diabetics (159).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [159] Papamichou, 2019, Dietary patterns and management of type 2 diabetes: a systematic review of randomised clinical trials, Nutr Metab Cardiovasc Dis. source
Not checked in the free run.
May combine two claims.
PremisecitationThiazolidinediones can promote insulin sensitivity, increase glucose metabolism, and preserve β-cell function through activating PPAR-γ.
“Also, thiazolidinediones can promote insulin sensitivity, increase glucose metabolism, and preserve the β-cell function through activating PPAR-γ (185, 186).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [185] Tyagi, 2011, The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases, J Adv Pharmac Technol Res. source
Not checked in the free run.
- cites [186] Wendy, 2018, An aPPARent functional consequence in skeletal muscle physiology via peroxisome proliferator-activated receptors, Int J Mol Sci. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMetformin is considered one of the most prevalent medications for diabetes management.
“Metformin is considered as one of the most prevalent medications for diabetes management (179).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [179] Vallianou, 2019, Metformin and gut microbiota: their interactions and their impact on diabetes, Hormones (Athens). source
Not checked in the free run.
May combine two claims.
PremisecitationMetformin decreases fasting plasma glucose concentration and hemoglobin A1c by conserving β-cell function or by decreasing liver glucose production (hepatic gluconeogenesis).
“A considerable number of studies have also found that metformin decreases fasting plasma glucose (PG) concentration and hemoglobin A1c by conserving the β-cell function or by decreasing liver glucose production (hepatic gluconeogenesis) (181–184).”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [181] DeFronzo, 1991, Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects, J Clin Endocrinol Metab. source
Not checked in the free run.
- cites [182] DeFronzo, 1995, Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. the multicenter metformin study group, N Engl J Med. source
Not checked in the free run.
- cites [183] Foretz, 2019, Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus, Nat Rev Endocrinol. source
Not checked in the free run.
- cites [184] Turner, 1999, Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) group, JAMA. source
Not checked in the free run.
May combine two claims.
PremisecitationIn an RCT, both electrical acupuncture with oral essential amino acids and oral essential amino acids alone can decrease BF% and increase ASM/H2, with the combination group being more effective.
“A randomized controlled trial, using electrical acupuncture coupled with essential amino acid supplementation to treat SO in male older people, has indicated that both electrical acupuncture with oral essential amino acids group and oral essential amino acids alone group can decrease BF% and increase ASM/H2, with the combination group being more effective than another group.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [197] Zhou, 2018, The effects of electrical acupuncture and essential amino acid supplementation on sarcopenic obesity in male older adults: a randomized control study, Obes Facts. source
Not checked in the free run.
May combine two claims.
PremisecitationIn that study, strength increased more in the resistance group (19% increase) than in the combination group (18% increase) and aerobic group (4% increase).
“But strength increased more in the resistance group (19% increase) than in the combination group (18% increase) and aerobic group (4% increase).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [171] Villareal, 2017, Aerobic or resistance exercise, or both, in dieting obese older adults, N Engl J Med. source
Not checked in the free run.
May combine two claims.
PremisecitationHigh-intensity interval training was not able to regulate fasting plasma glucose, insulin, C-peptide, proinsulin, and free fatty acids, nor first-phase and late-phase plasma glucose, insulin, C-peptide, and proinsulin.
“Noteworthy, high-intensity interval training was not able to regulate the levels of fasting plasma glucose, insulin, C-peptide, pro- insulin, and free fatty acids, nor did the levels of first-phase (0–30 min) and late-phase (30–180 min) plasma glucose, insulin, C-peptide, and proinsulin (174).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [174] Nieuwoudt, 2017, Functional high-intensity training improves pancreatic β-cell function in adults with type 2 diabetes, Am J Physiol Endocrinol Metab. source
Not checked in the free run.
May combine two claims.
PremisecitationHigh-intensity interval training reduced total body-fat percentage and protected lean body mass.
“The total body-fat percentage was reduced, whereas lean body mass was protected.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [174] Nieuwoudt, 2017, Functional high-intensity training improves pancreatic β-cell function in adults with type 2 diabetes, Am J Physiol Endocrinol Metab. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationNICE guidance for adults with type 2 diabetes recommends standard-release metformin as the initial drug treatment.
“Based on existing evidence, the National Institute for Health and Care Excellence (NICE) guidance for adults with type 2 diabetes recommends standard-release metformin as the initial drug treatment (180).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [180] 2019, Type 2 Diabetes In Adults: Management
Not checked in the free run.
May combine two claims.
PremisecitationIncretins can shrink appetite, reduce food intake, and lead to weight reduction.
“Moreover, incretins can shrink appetite, thus reduce food intake, leading to weight reduction (192).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [192] Tasyurek, 2014, Incretins: their physiology and application in the treatment of diabetes mellitus, Diabetes Metab Res Rev. source
Not checked in the free run.
May combine two claims.
PremisecitationResistance training can improve flexibility, muscle strength, and muscle hypertrophy, while aerobic training focuses on increasing physical endurance of older people.
“Meanwhile, as resistance training can improve flexibility, muscle strength, and muscle hypertrophy, aerobic training focuses on increasing physical endurance of older people (166).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [166] Batsis, 2018, Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies, Nat Rev Endocrinol. source
Not checked in the free run.
May combine two claims.
PremisecitationAcupuncture has been used in diabetes for a long time in Asian countries, and recent studies have suggested that acupuncture may alleviate sarcopenic obesity.
“Acupuncture has been used in diabetes for a long time in Asian countries and recent studies have also suggested that acupuncture may alleviate SO (197–199).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [197] Zhou, 2018, The effects of electrical acupuncture and essential amino acid supplementation on sarcopenic obesity in male older adults: a randomized control study, Obes Facts. source
Not checked in the free run.
- cites [198] Liao, 2018, Effect of heat-producing needling technique on the local skin temperature: clinical dataset, Data. source
Not checked in the free run.
- cites [199] Wang, 2020, Mechanism of traditional chinese medicine in treating knee osteoarthritis, J Pain Res. source
Not checked in the free run.
May combine two claims.
PremisecitationSGLT2 inhibitors decrease reabsorption of glucose in the kidney and lower FPG and A1C, enhancing urinary glucose elimination and attenuating blood glucose level.
“In addition, Sodium-Glucose Cotransporter (SGLT) 2 Inhibitors are one of the latest pharmacological interventions to decrease the reabsorption of glucose in kidney and lower FGP and A1C, which enhances urinary glucose elimination and attenuates blood glucose level.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [194] List, 2011, Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans, Kidney Int. source
Not checked in the free run.
May combine two claims.
InterpretationcitationThe combination of resistance and aerobic training improves A1C in diabetics, which could hardly be obtained by each training exercise alone.
“Therefore, in spite of the benefits of resistance training alone and aerobic training alone on diabetics, the combination of both could improve the level of A1C, which could hardly be obtained by each training exercise alone (175).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [175] Church, 2010, Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial, JAMA. source
Not checked in the free run.
May combine two claims.
Premisecitationα-Glucosidase inhibitors prolong overall carbohydrate digestion duration and reduce the rate of glucose absorption.
“Besides, α-Glucosidase Inhibitors contribute for prolonging the overall carbohydrate digestion duration and reducing the rate of glucose absorption (189).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [189] Teng, 2017, α-Glucosidase and α-amylase inhibitors from seed oil: a review of liposoluble substance to treat diabetes, Crit Rev Food Sci Nutr. source
Not checked in the free run.
May combine two claims.
PremisecitationIn an American RCT, compared to control, there were no significant mean changes of A1C in either the resistance training alone group (−0.16%; 95% CI: −0.46-0.15%; P = 0.32) or the aerobic training alone group (−0.24%; 95% CI: −0.55-0.07%; P = 0.14).
“Compared to control group, there were no significant mean changes of A1C in either the resistance training alone group (−0.16%; 95% CI: −0.46–0.15%; P = 0.32) or the aerobic training alone group (-0.24%; 95% CI: −0.55–0.07%; P = 0.14)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [175] Church, 2010, Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial, JAMA. source
Not checked in the free run.
May combine two claims.
PremisecitationIn an RCT, pancreatic fat decreased in both the healthy group (from 4.4 to 3.6%) and the prediabetes/T2D group (from 8.7 to 6.7%), without significant differences observed for improvement of β-cell function in different exercise strategies.
“The amount of pancreatic fat decreased in both healthy group (from 4.4 to 3.6%) and prediabetes/T2D group (from 8.7 to 6.7%), without significant differences observed for the improvement of β-cell function in different exercise strategies (173).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [173] Heiskanen, 2018, Exercise training decreases pancreatic fat content and improves beta cell function regardless of baseline glucose tolerance: a randomised controlled trial, Diabetologia. source
Not checked in the free run.
May combine two claims.
PremisecitationThiazolidinediones can reduce plasma free fatty acid and intramyocellular lipid content to increase insulin sensitivity and redistribute fats from visceral to subcutaneous adipose to alleviate diabetes.
“Meanwhile, they can reduce plasma free fatty acid and intramyocellular lipid content to increase insulin sensitivity and redistribute fats from visceral to subcutaneous adipose to alleviate diabetes.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [185] Tyagi, 2011, The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases, J Adv Pharmac Technol Res. source
Not checked in the free run.
- cites [186] Wendy, 2018, An aPPARent functional consequence in skeletal muscle physiology via peroxisome proliferator-activated receptors, Int J Mol Sci. source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenPhysical activity is helpful for both sarcopenic obesity and diabetes.
“Noteworthily, physical activity is helpful for both SO and diabetes.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe overall quality of evidence for herbal medicine and derivatives and acupuncture is low, and available data are too few to adequately suggest they are useful.
“Although several studies have revealed some positive results, the overall quality of the evidence is low, and the available data are too few to adequately suggest that herbal medicine and derivative and acupuncture are useful.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
InterpretationreasoningSarcopenic obesity may have a synergistic effect with low-grade inflammation to exacerbate insulin resistance, further impairing glucose metabolism.
“Therefore, SO may have synergistic effect with low-grade inflammation to exacerbate insulin resistance, further impairing glucose metabolism.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn the case of similar BMI, diabetics have decreased lean body mass and increased body fat mass compared with non-diabetics.
“a study has found that in the case of similar BMI, diabetics have decreased lean body mass and increased body fat mass compared with non-diabetics (57)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [57] Kim, 2010, Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS), Diabetes Care. source
Not checked in the free run.
The paper relies on this without support.
There is currently no consistent diagnosis of sarcopenic obesity.
“There is currently no consistent diagnosis of SO, nevertheless an adequate one should include the individual diagnosis of obesity and sarcopenia.”
The paper relies on this without support.
Healthy diet and physical activity are beneficial to both sarcopenic obesity and diabetes, but there are only recommended drugs for diabetes.
“Healthy diet and physical activity are beneficial to both sarcopenic obesity and diabetes, but there are only recommended drugs for diabetes.”
The paper relies on this without support.
Sarcopenic obesity is more common in older people due to the natural changes in body composition.
“Although SO is more common in older people due to the natural changes in body composition, it is estimated that younger people with class II or III obesity are vulnerable as well.”
The paper relies on this without support.
The main dietary interventions for sarcopenic obesity consist of caloric restriction, protein intake, and micronutrient supplementation.
“The main dietary interventions for SO consist of caloric restriction, protein intake, and micronutrient supplementation.”
The paper relies on this without support.
There is a lack of proper randomized clinical trials for dietary interventions for sarcopenic obesity, so expert opinion is the major guideline at present.
“It is noted that lack of proper randomized clinical trials (RCTs) makes expert opinions to be the major guidelines at present of dietary interventions for SO.”
The paper relies on this without support.
The most common treatments of sarcopenic obesity and diabetes are dietary intervention and physical activity.
“The most common treatments of SO and diabetes are dietary intervention and physical activity.”
The paper relies on this without support.
Metformin causes deficiency in vitamin B12 and folic acid.
“Metformin has been reported to cause deficiency in vitamin 12 and folic acid.”
The paper relies on this without support.
Thiazolidinediones can cause bladder cancer and fractures, and combined insulin-thiazolidinediones therapy may lead to heart failure.
“Thiazolidinediones can cause bladder cancer and fractures, and combined insulin-thiazolidinediones therapy may lead to heart failure.”
The paper relies on this without support.
Common adverse reactions of SGLT2 inhibitors are urinary tract infections, increase in LDL cholesterol, bone fractures, and they may sometimes cause ketoacidosis.
“The common adverse reactions of SGLT2 inhibitors are urinary tract infections, increase in low-density lipoprotein (LDL) cholesterol, bone fractures, and they may sometimes cause ketoacidosis.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Current BIA devices cannot accurately quantify muscle mass, for it indirectly reflects whole body composition, which is influenced by fluid and food intake, internal body fat, and disease-related conditions.
“However, current BIA devices cannot accurately quantify muscle mass, for it indirectly reflects whole body composition, which is influenced by fluid and food intake, internal body fat, and disease‐related conditions.[ 115 ]”
From Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review (2022) · cites this paper as [115]
Therapeutic weight loss targeting excess fat inevitably leads to loss of variable amounts of skeletal muscle mass, which may be more pronounced in individuals with predisposing catabolic conditions, following bariatric surgery, or with inappropriate dietary regimens and weight cycling.
“Importantly, therapeutic weight loss targeting excess fat inevitably leads to loss of variable amounts of skeletal muscle mass, which may be more pronounced in individuals with predisposing catabolic conditions (chronic diseases, ageing), following bariatric surgery (particularly in the absence of nutritional supervision and follow-up) or in the presence of long-lasting inappropriate or unbalanced”
From Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement (2022) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Acupuncture meta-analysis citation identifies a case report
MinorThe claimed meta-analysis is cited as reference 195, but that reference is identified as a case report involving two patients.
“Besides, a meta-analysis of randomized controlled trials has confirmed that acupuncture should be recommended as a complementary treatment in T2D control, particularly with obesity or other metabolic disorders (195).”
“195. Hwang JH Jung HW. Effects of pharmacopuncture with wild ginseng complex in 2 elderly patients with obesity: case report.”
Muscle-strength mortality estimate is not higher than the skeletal-muscle-mass estimate
MinorThe text says mortality is higher when sarcopenic obesity is defined by muscle strength than when it is defined by skeletal muscle mass. Its reported hazard ratios are 1.23 and 1.24, respectively, so the muscle-strength estimate is slightly lower.
“all-cause mortality is higher basing on the criteria of mid-arm muscle circumference or muscle strength”
“HR 1.46, 95% CI 1.23–1.73 and 1.23, 1.09–1.38, respectively) rather than on the definition of skeletal muscle mass (pooled HR 1.24, 95% CI 1.12–1.37, P < 0.001)”
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818 · see citing works
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601 · see citing works
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197 · see citing works
Garber, C. E., Blissmer, B., Deschenes, M. R., Franklin, B. A., Lamonte, M. J., Lee, I.-M., Nieman, D. C., & Swain, D. P. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318213fefb · Cited by 9,319 · see citing works
Lang, G. E., Vaiser, A., Snyder, W. B., & Lynn, J. R. (1974) · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583 · see citing works
Epidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004 · see citing works
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803 · see citing works
Cheung, N., Mitchell, P., & Wong, T. Y. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62124-3 · Cited by 3,288 · see citing works
Janssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139 · cited 1× · see citing works
“(139) proposed a definition of sarcopenia that the skeletal muscle mass index [skeletal muscle mass (kg)/weight (kg)× 100] is one or two standard deviations below the reference value of younger, healthy individuals measured by BIA.”
BackgroundPhysical activity/exercise and diabetes: A position statement of the American Diabetes Association
Colberg, S. R., Sigal, R. J., Yardley, J. E., Riddell, M. C., Dunstan, D. W., Dempsey, P. C., Horton, E. S., Castorino, K., & Tate, D. F. (2016) · Diabetes Care · doi:10.2337/dc16-1728 · Cited by 2,991 · see citing works
Muscles, exercise and obesity: skeletal muscle as a secretory organ
Pedersen, B. K., & Febbraio, M. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.49 · Cited by 2,909 · see citing works
Diabetic Kidney Disease: Challenges, Progress, and Possibilities
Alicic, R. Z., Rooney, M. T., & Tuttle, K. R. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11491116 · Cited by 2,898 · see citing works
Bauer, J., Biolo, G., Cederholm, T., Cesari, M., Cruz-Jentoft, A. J., Morley, J. E., Phillips, S., Sieber, C., Stehle, P., Teta, D., et al. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.05.021 · Cited by 2,553 · see citing works
Classification and Diagnosis of Diabetes
Fajans, S. S. (1990) · Medical Entomology and Zoology · Cited by 2,356 · see citing works
Mourtzakis, M., Prado, C. M. M., Lieffers, J. R., Reiman, T., McCargar, L. J., & Baracos, V. E. (2008) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h08-075 · Cited by 2,224 · see citing works
Sugar-Sweetened Beverages and Risk of Metabolic Syndrome and Type 2 Diabetes
Malik, V. S., Popkin, B. M., Bray, G. A., Després, J.-P., Willett, W. C., & Hu, F. B. (2010) · Diabetes Care · doi:10.2337/dc10-1079 · Cited by 2,116 · see citing works
Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard, J., Maachi, M., Lagathu, C., Kim, M. J., Caron, M., Vidal, H., Capeau, J., & Fève, B. (2006) · PubMed · Cited by 2,069 · see citing works
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
Kautzky-Willer, A., Harreiter, J., & Pacini, G. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1137 · Cited by 2,043 · see citing works
Colberg, S. R., Sigal, R. J., Fernhall, B., Regensteiner, J. G., Blissmer, B. J., Rubin, R. R., Chasan-Taber, L., Albright, A. L., & Braun, B. (2010) · Diabetes Care · doi:10.2337/dc10-9990 · Cited by 1,955 · see citing works
Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952 · see citing works
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914 · see citing works
(2) Classification and diagnosis of diabetes
American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc15-s005 · Cited by 1,841 · see citing works
Obesity, Inflammation, and Insulin Resistance
Shoelson, S. E., Herrero, L., & Naaz, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.059 · Cited by 1,806 · see citing works
Deutz, N. E. P., Bauer, J. M., Barazzoni, R., Biolo, G., Boirie, Y., Bosy-Westphal, A., Cederholm, T., Cruz-Jentoft, A., Krznariç, Z., Nair, K. S., et al. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2014.04.007 · Cited by 1,738 · see citing works
Feldman, E. L., Callaghan, B. C., Pop-Busui, R., Zochodne, D. W., Wright, D. E., Bennett, D. L., Bril, V., Russell, J. W., & Viswanathan, V. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0092-1 · Cited by 1,697 · see citing works
Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management
Chaudhury, A., Duvoor, C., Reddy Dendi, V. S., Kraleti, S., Chada, A., Ravilla, R., Marco, A., Shekhawat, N. S., Montales, M. T., Kuriakose, K., et al. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00006 · Cited by 1,500 · see citing works
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
Batsis, J. A., & Villareal, D. T. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0062-9 · Cited by 1,382 · see citing works
Efficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes Mellitus
DeFronzo, R. A., & Goodman, A. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508313330902 · Cited by 1,368 · see citing works
Pathogenesis of type 2 diabetes mellitus
DeFronzo, R. A. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.013 · Cited by 1,342 · see citing works
Leon, B. M. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i13.1246 · Cited by 1,215 · see citing works
Body Composition in Healthy Aging
BAUMGARTNER, R. N. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06498.x · Cited by 1,078 · see citing works
Robertson, R. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400019200 · Cited by 1,078 · see citing works
Sarcopenic obesity: definition, cause and consequences
Stenholm, S., Harris, T. B., Rantanen, T., Visser, M., Kritchevsky, S. B., & Ferrucci, L. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328312c37d · Cited by 1,070 · see citing works
Tyagi, S., Gupta, P., Saini, A., Kaushal, C., & Sharma, S. (2011) · Journal of Advanced Pharmaceutical Technology & Research · doi:10.4103/2231-4040.90879 · Cited by 1,017 · see citing works
TNF and ROS crosstalk in inflammation
Blaser, H., Dostert, C., Mak, T. W., & Brenner, D. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.12.002 · Cited by 1,008 · see citing works
Sarcopenia: alternative definitions and associations with lower extremity function
Newman, A. B., Kupelian, V., Visser, M., Simonsick, E., Goodpaster, B., Nevitt, M., Kritchevsky, S. B., Tylavsky, F. A., Rubin, S. M., Harris, T. B., et al. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51534.x · Cited by 981 · see citing works
Church, T. S., Blair, S. N., Cocreham, S., Johannsen, N., Johnson, W., Kramer, K., Mikus, C. R., Myers, V., Nauta, M., Rodarte, R. Q., et al. (2010) · JAMA · doi:10.1001/jama.2010.1710 · Cited by 944 · see citing works
Insulin resistance: review of the underlying molecular mechanisms
Yaribeygi, H., Farrokhi, F. R., Butler, A. E., & Sahebkar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27603 · Cited by 929 · see citing works
Kalinkovich, A., & Livshits, G. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.008 · Cited by 882 · see citing works
Aune, D., Norat, T., Leitzmann, M., Tonstad, S., & Vatten, L. J. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-015-0056-z · Cited by 880 · see citing works
Molecular mechanisms of ROS production and oxidative stress in diabetes
Newsholme, P., Cruzat, V. F., Keane, K. N., Carlessi, R., & de Bittencourt, P. I. H. (2016) · Biochemical Journal · doi:10.1042/bcj20160503c · Cited by 878 · see citing works
Dietary protein recommendations and the prevention of sarcopenia
Paddon-Jones, D., & Rasmussen, B. B. (2009) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32831cef8b · Cited by 823 · see citing works
Aerobic or Resistance Exercise, or Both, in Dieting Obese Older Adults
Villareal, D. T., Aguirre, L., Gurney, A. B., Waters, D. L., Sinacore, D. R., Colombo, E., Armamento-Villareal, R., & Qualls, C. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1616338 · Cited by 754 · see citing works
α-Glucosidase Inhibitors for Patients With Type 2 Diabetes
van de Laar, F. A., Lucassen, P. L., Akkermans, R. P., van de Lisdonk, E. H., Rutten, G. E., & van Weel, C. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.154 · Cited by 690 · see citing works
Akash, M. S. H., Rehman, K., & Liaqat, A. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26174 · Cited by 690 · see citing works
Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
Foretz, M., Guigas, B., & Viollet, B. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0242-2 · Cited by 686 · see citing works
Pathogenesis of insulin resistance in skeletal muscle
Abdul-Ghani, M. A., & DeFronzo, R. A. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/476279 · Cited by 670 · see citing works
Oxidative Stress, Molecular Inflammation and Sarcopenia
Meng, S.-J., & Yu, L.-J. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11041509 · Cited by 637 · see citing works
Reactive oxygen species (ROS) in macrophage activation and function in diabetes
Rendra, E., Riabov, V., Mossel, D. M., Sevastyanova, T., Harmsen, M. C., & Kzhyshkowska, J. (2019) · Immunobiology · doi:10.1016/j.imbio.2018.11.010 · Cited by 636 · see citing works
Is Alzheimer’s disease a type 3 diabetes? A critical appraisal
Kandimalla, R., Thirumala, V., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.08.018 · Cited by 621 · see citing works
Sarcopenic obesity and inflammation in the InCHIANTI study
Schrager, M. A., Metter, E. J., Simonsick, E., Ble, A., Bandinelli, S., Lauretani, F., & Ferrucci, L. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00627.2006 · Cited by 594 · see citing works
Prevalence and Determinant Factors of Sarcopenia in Patients With Type 2 Diabetes
Kim, T. N., Park, M. S., Yang, S. J., Yoo, H. J., Kang, H. J., Song, W., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., et al. (2010) · Diabetes Care · doi:10.2337/dc09-2310 · Cited by 585 · see citing works
Diabetic nephropathy &ndash; complications and treatment
Lim, A. (2014) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s40172 · Cited by 583 · see citing works
Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
Mota, M., Banini, B. A., Cazanave, S. C., & Sanyal, A. J. (2016) · Metabolism · doi:10.1016/j.metabol.2016.02.014 · Cited by 570 · see citing works
Update of pathophysiology and management of diabetic kidney disease
Lin, Y., Chang, Y.-H., Yang, S., Wu, K., & Chu, T. (2018) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.02.007 · Cited by 564 · see citing works
Impact of diabetes on cardiovascular disease: an update
Matheus, A. S. D. M., Tannus, L. R. M., Cobas, R. A., Palma, C. C. S., Negrato, C. A., & Gomes, M. D. B. (2013) · International Journal of Hypertension · doi:10.1155/2013/653789 · Cited by 547 · see citing works
Ferrando, A. A., Sheffield-Moore, M., Yeckel, C. W., Gilkison, C., Jiang, J., Achacosa, A., Lieberman, S. A., Tipton, K., Wolfe, R. R., & Urban, R. J. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00362.2001 · Cited by 522 · see citing works
From pre-diabetes to diabetes: diagnosis, treatments and translational research
Khan, R., Chua, Z., Tan, J., Yang, Y., Liao, Z., & Zhao, Y. (2019) · Medicina · doi:10.3390/medicina55090546 · Cited by 484 · see citing works
Self-citationInflamed fat: what starts the fire?
Neels, J. G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27280 · Cited by 463 · see citing works
Pathophysiology of Diabetic Retinopathy
Tarr, J. M., Kaul, K., Chopra, M., KOHNER, E. M., & Chibber, R. (2013) · ISRN Ophthalmology · doi:10.1155/2013/343560 · Cited by 460 · see citing works
Depression in type 2 diabetes mellitus: prevalence, impact, and treatment
Semenkovich, K., Brown, M. E., Svrakic, D. M., & Lustman, P. J. (2015) · Drugs · doi:10.1007/s40265-015-0347-4 · Cited by 447 · see citing works
Davison, K. K., Ford, E. S., Cogswell, M. E., & Dietz, W. H. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50508.x · Cited by 435 · see citing works
Inflammatory mediators and islet ?-cell failure: a link between type 1 and type 2 diabetes
Donath, M. Y., St�rling, J., Maedler, K., & Mandrup-Poulsen, T. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0450-y · Cited by 422 · see citing works
Cho, S. S., Qi, L., Fahey Jr, G. C., & Klurfeld, D. M. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.067629 · Cited by 421 · see citing works
Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects
DEFRONZO, R. A., BARZILAI, N., & SIMONSON, D. C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-6-1294 · Cited by 408 · see citing works
Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity
Wannamethee, S. G., & Atkins, J. L. (2015) · Proceedings of the Nutrition Society · doi:10.1017/s002966511500169x · Cited by 404 · see citing works
Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Kawakubo, M., & Buchanan, T. A. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-1066 · Cited by 402 · see citing works
Kim, T. N., Yang, S. J., Yoo, H. J., Lim, K. I., Kang, H. J., Song, W., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., et al. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.130 · Cited by 401 · see citing works
Type-2 diabetes mellitus and cardiovascular disease
Henning, R. J. (2018) · Future Cardiology · doi:10.2217/fca-2018-0045 · Cited by 398 · see citing works
Hong, S.-H., & Choi, K. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020494 · Cited by 390 · see citing works
Kuriyan, R. (2018) · Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1777_18 · Cited by 384 · see citing works
Vinik, A. I., Nevoret, M.-L., Casellini, C., & Parson, H. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.06.001 · Cited by 366 · see citing works
Baracos, V. E., & Arribas, L. (2018) · Annals of Oncology · doi:10.1093/annonc/mdx810 · Cited by 362 · see citing works
Diabetes and breast cancer risk: A meta-analysis
Boyle, P., Boniol, M., Koechlin, A., Robertson, C., Valentini, F., Coppens, K., Fairley, L.-L., Boniol, M., Zheng, T., Zhang, Y., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.414 · Cited by 358 · see citing works
Heymsfield, S. B., Gonzalez, M. C. C., Shen, W., Redman, L., & Thomas, D. (2014) · Obesity Reviews · doi:10.1111/obr.12143 · Cited by 350 · see citing works
Insulin and its receptor: structure, function and evolution
De Meyts, P. (2004) · BioEssays · doi:10.1002/bies.20151 · Cited by 345 · see citing works
Sarcopenia and sarcopenic obesity
Choi, K. M. (2016) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.193 · Cited by 344 · see citing works
Physical Activity/Exercise and Diabetes
American Diabetes Association (2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s58 · Cited by 343 · see citing works
Cancer-associated fibroblasts in tumor microenvironment–Accomplices in tumor malignancy
Liao, Z., Tan, Z. W., Zhu, P., & Tan, N. S. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2017.12.003 · Cited by 335 · see citing works
Self-citationDonini, L. M., Busetto, L., Bauer, J. M., Bischoff, S., Boirie, Y., Cederholm, T., Cruz-Jentoft, A. J., Dicker, D., Frühbeck, G., Giustina, A., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2019.11.024 · Cited by 326 · see citing works
Chen, H., Chung, Y., Chen, Y., Ho, S., & Wu, H. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14722 · Cited by 317 · see citing works
Bouchard, D. R., Dionne, I. J., & Brochu, M. (2009) · Obesity · doi:10.1038/oby.2009.109 · Cited by 314 · see citing works
Sarcopenic-obesity and cardiovascular disease risk in the elderly
Stephen, W. C., & Janssen, I. (2009) · The Journal of nutrition, health and aging · doi:10.1007/s12603-009-0084-z · Cited by 301 · see citing works
Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link
Zhang, Y., Huang, N.-Q., Yan, F., Jin, H., Zhou, S.-Y., Shi, J.-S., & Jin, F. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.11.015 · Cited by 301 · see citing works
Nolan, C. J., & Prentki, M. (2019) · Diabetes and Vascular Disease Research · doi:10.1177/1479164119827611 · Cited by 292 · see citing works
Reactive oxygen species: a volatile driver of field cancerization and metastasis
Liao, Z., Chua, D., & Tan, N. S. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0961-y · Cited by 284 · see citing works
Self-citationDiabetes mellitus – Definition, Klassifikation, Diagnose, Screening und Prävention (Update 2019)
Harreiter, J., & Roden, M. (2019) · Wiener klinische Wochenschrift · doi:10.1007/s00508-019-1450-4 · Cited by 276 · see citing works
Tian, S., & Xu, Y. (2016) · Geriatrics & Gerontology International · doi:10.1111/ggi.12579 · Cited by 274 · see citing works
Forouhi, N. G., Sattar, N., Tillin, T., McKeigue, P. M., & Chaturvedi, N. (2006) · Diabetologia · doi:10.1007/s00125-006-0393-2 · Cited by 271 · see citing works
Obesity and cancer: existing and new hypotheses for a causal connection
Stone, T. W., McPherson, M., & Gail Darlington, L. (2018) · eBioMedicine · doi:10.1016/j.ebiom.2018.02.022 · Cited by 262 · see citing works
Metabolomics of type 1 and type 2 diabetes
Arneth, B., Arneth, R., & Shams, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102467 · Cited by 262 · see citing works
Hsu, K.-J., Liao, C.-D., Tsai, M.-W., & Chen, C.-N. (2019) · Nutrients · doi:10.3390/nu11092163 · Cited by 258 · see citing works
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-9-201305070-00603 · Cited by 251 · see citing works
Sarcopenic obesity: time to meet the challenge
Barazzoni, R., Bischoff, S., Boirie, Y., Busetto, L., Cederholm, T., Dicker, D., Toplak, H., Van Gossum, A., Yumuk, V., & Vettor, R. (2018) · Obesity Facts · doi:10.1159/000490361 · Cited by 244 · see citing works
The role of exercise-induced myokines in regulating metabolism
Huh, J. Y. (2018) · Archives of Pharmacal Research · doi:10.1007/s12272-017-0994-y · Cited by 242 · see citing works
Diabetic Retinopathy in the Context of Patients with Diabetes
Simó‐Servat, O., Hernández, C., & Simó, R. (2019) · Ophthalmic Research · doi:10.1159/000499541 · Cited by 240 · see citing works
Obesity, insulin resistance, and type 1 diabetes mellitus
Polsky, S., & Ellis, S. L. (2015) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000170 · Cited by 235 · see citing works
Bosy-Westphal, A., Jensen, B., Braun, W., Pourhassan, M., Gallagher, D., & Müller, M. J. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.27 · Cited by 231 · see citing works
Chronic oxidative stress as a mechanism for glucose toxicity of the beta cell in type 2 diabetes
Robertson, R. P., Zhou, H., Zhang, T., & Harmon, J. S. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0026-5 · Cited by 222 · see citing works
Polyzos, S. A., & Margioris, A. N. (2018) · Hormones · doi:10.1007/s42000-018-0049-x · Cited by 212 · see citing works
Exercise and nutrition strategies to counteract sarcopenic obesity
Trouwborst, I., Verreijen, A., Memelink, R., Massanet, P., Boirie, Y., Weijs, P., & Tieland, M. (2018) · Nutrients · doi:10.3390/nu10050605 · Cited by 210 · see citing works
Risk of knee osteoarthritis with obesity, sarcopenic obesity, and sarcopenia
Misra, D., Fielding, R. A., Felson, D. T., Niu, J., Brown, C., Nevitt, M., Lewis, C. E., Torner, J., Neogi, T., & study, T. M. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40692 · Cited by 209 · see citing works
Kim, T. N., Park, M. S., Lim, K. I., Choi, H. Y., Yang, S. J., Yoo, H. J., Kang, H. J., Song, W., Choi, H., Baik, S. H., et al. (2013) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04433.x · Cited by 208 · see citing works
Adipose tissue, obesity and non-alcoholic fatty liver disease
Polyzos, S. A., Kountouras, J., & Mantzoros, C. S. (2017) · Minerva Endocrinology · doi:10.23736/s0391-1977.16.02563-3 · Cited by 207 · see citing works
Bellia, A., Garcovich, C., D’Adamo, M., Lombardo, M., Tesauro, M., Donadel, G., Gentileschi, P., Lauro, D., Federici, M., Lauro, R., et al. (2013) · Internal and Emergency Medicine · doi:10.1007/s11739-011-0559-x · Cited by 206 · see citing works
Papanicolaou, D. A., Ather, S. N., Zhu, H., Zhou, Y., Lutkiewicz, J., Scott, B. B., & Chandler, J. (2013) · The Journal of nutrition, health and aging · doi:10.1007/s12603-013-0335-x · Cited by 196 · see citing works
Inflammation: roles in aging and sarcopenia
Jensen, G. L. (2008) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607108324585 · Cited by 195 · see citing works
Physical Activity, Exercise and Diabetes
Riddell, M. C., & Sigal, R. J. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.10.001 · Cited by 192 · see citing works
Mortality and Hospitalization in Patients After Amputation
Schofield, C. J., Libby, G., Brennan, G. M., MacAlpine, R., Morris, A. D., & Leese, G. (2006) · Diabetes Care · doi:10.2337/dc06-0926 · Cited by 192 · see citing works
Joseph, A., Adhihetty, P. J., & Leeuwenburgh, C. (2016) · The Journal of Physiology · doi:10.1113/jp270659 · Cited by 186 · see citing works
The Cardiometabolic Syndrome and Sarcopenic Obesity in Older Persons
Dominguez, L. J., & Barbagallo, M. (2007) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4564.2007.06673.x · Cited by 185 · see citing works
Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans
List, J. F., & Whaley, J. M. (2011) · Kidney International · doi:10.1038/ki.2010.512 · Cited by 184 · see citing works
Camporez, J.-P. G., Petersen, M. C., Abudukadier, A., Moreira, G. V., Jurczak, M. J., Friedman, G., Haqq, C. M., Petersen, K. F., & Shulman, G. I. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525795113 · Cited by 184 · see citing works
Baek, S. J., Nam, G. E., Han, K. D., Choi, S. W., Jung, S. W., Bok, A. R., Kim, Y. H., Lee, K. S., Han, B. D., & Kim, D. H. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-013-0011-3 · Cited by 182 · see citing works
Lee, S., Kim, T., & Kim, S. (2012) · Arthritis & Rheumatism · doi:10.1002/art.37696 · Cited by 182 · see citing works
Papamichou, D., Panagiotakos, D. B., & Itsiopoulos, C. (2019) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.02.004 · Cited by 182 · see citing works
Farrell, G. C., Haczeyni, F., & Chitturi, S. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-10-8684-7_3 · Cited by 178 · see citing works
Physical Activity and Sarcopenic Obesity: Definition, Assessment, Prevalence and Mechanism
Lee, D.-C., Shook, R. P., Drenowatz, C., & Blair, S. N. (2016) · Future Science OA · doi:10.4155/fsoa-2016-0028 · Cited by 177 · see citing works
Sarcopenic Obesity: Epidemiologic Evidence, Pathophysiology, and Therapeutic Perspectives
Koliaki, C., Liatis, S., Dalamaga, M., & Kokkinos, A. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00359-9 · Cited by 176 · see citing works
Spyrou, A., Natsis, K. S., Papamichalis, E., & Mourtzinos, H. (2019) · Age and Ageing · doi:10.1093/ageing/afz020 · Cited by 174 · see citing works
Zamboni, M., Rubele, S., & Rossi, A. P. (2019) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000519 · Cited by 173 · see citing works
Sarcopenia in the elderly: basic and clinical issues
Wang, C., & Bai, L. (2012) · Geriatrics & Gerontology International · doi:10.1111/j.1447-0594.2012.00851.x · Cited by 170 · see citing works
Chang, J. S., Kim, T. H., Nguyen, T. T., Park, K., Kim, N., & Kong, I. D. (2017) · Geriatrics & Gerontology International · doi:10.1111/ggi.13030 · Cited by 166 · see citing works
Gao, C., Hölscher, C., Liu, Y., & Li, L. (2012) · revneuro · doi:10.1515/rns.2011.061 · Cited by 164 · see citing works
Freiberger, E., Goisser, S., Porzel, S., Volkert, D., Kemmler, W., Sieber, C., & Bollheimer, C. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s82454 · Cited by 162 · see citing works
Teng, H., & Chen, L. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1129309 · Cited by 162 · see citing works
Clinical implications of sarcopenic obesity in cancer
Carneiro, I. P., Mazurak, V. C., & Prado, C. M. (2016) · Current Oncology Reports · doi:10.1007/s11912-016-0546-5 · Cited by 162 · see citing works
Clarke, P. M., Glasziou, P., Patel, A., Chalmers, J., Woodward, M., Harrap, S. B., Salomon, J. A., & on behalf of the ADVANCE Collaborative Group (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000236 · Cited by 159 · see citing works
Irisin and musculoskeletal health
Colaianni, G., Cinti, S., Colucci, S., & Grano, M. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13345 · Cited by 158 · see citing works
Diabetes and cancer: Epidemiological and biological links
Wang, M., Yang, Y., & Liao, Z. (2020) · World Journal of Diabetes · doi:10.4239/wjd.v11.i6.227 · Cited by 158 · see citing works
Self-citationDíaz-López, A., Babio, N., Martínez-González, M. A., Corella, D., Amor, A. J., Fitó, M., Estruch, R., Arós, F., Gómez-Gracia, E., Fiol, M., et al. (2015) · Diabetes Care · doi:10.2337/dc15-1117 · Cited by 147 · see citing works
Öztürk, Z. A., Türkbeyler, İ. H., Abiyev, A., Kul, S., Edizer, B., Yakaryılmaz, F. D., & Soylu, G. (2018) · Internal Medicine Journal · doi:10.1111/imj.13935 · Cited by 147 · see citing works
Nicklas, B. J., Chmelo, E., Delbono, O., Carr, J. J., Lyles, M. F., & Marsh, A. P. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.105270 · Cited by 144 · see citing works
Heiskanen, M. A., Motiani, K. K., Mari, A., Saunavaara, V., Eskelinen, J.-J., Virtanen, K. A., Koivumäki, M., Löyttyniemi, E., Nuutila, P., Kalliokoski, K. K., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4627-x · Cited by 142 · see citing works
Diabetes and Pancreatic Cancer: Chicken or Egg?
Magruder, J. T., Elahi, D., & Andersen, D. K. (2011) · Pancreas · doi:10.1097/mpa.0b013e318209e05d · Cited by 140 · see citing works
Metformin and gut microbiota: their interactions and their impact on diabetes
Vallianou, N. G., Stratigou, T., & Tsagarakis, S. (2019) · Hormones · doi:10.1007/s42000-019-00093-w · Cited by 138 · see citing works
Abbatecola, A. M., Paolisso, G., Fattoretti, P., Evans, W. J., Fiore, V., Dicioccio, L., & Lattanzio, F. (2011) · The Journal of nutrition, health and aging · doi:10.1007/s12603-011-0366-0 · Cited by 137 · see citing works
Current understandings of the pathogenesis of type 1 diabetes: genetics to environment
Giwa, A. M., Ahmed, R., Omidian, Z., Majety, N., Karakus, K. E., Omer, S. M., Donner, T., & Hamad, A. R. A. (2020) · World Journal of Diabetes · doi:10.4239/wjd.v11.i1.13 · Cited by 137 · see citing works
Insulin resistance and muscle strength in older persons
Abbatecola, A. M., Ferrucci, L., Ceda, G., Russo, C. R., Lauretani, F., Bandinelli, S., Barbieri, M., Valenti, G., & Paolisso, G. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.10.1278 · Cited by 135 · see citing works
Khadra, D., Itani, L., Tannir, H., Kreidieh, D., Masri, D. E., & Ghoch, M. E. (2019) · World Journal of Diabetes · doi:10.4239/wjd.v10.i5.311 · Cited by 130 · see citing works
Insulin resistance and chronic inflammation.
Matulewicz, N., & Karczewska‐Kupczewska, M. (2016) · PubMed · Cited by 130 · see citing works
Kim, J.-H., Cho, J. J., & Park, Y. S. (2015) · Journal of Korean Medical Science · doi:10.3346/jkms.2015.30.3.264 · Cited by 126 · see citing works
Incretins: their physiology and application in the treatment of diabetes mellitus
Tasyurek, H. M., Altunbas, H. A., Balci, M. K., & Sanlioglu, S. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2501 · Cited by 121 · see citing works
Johnson Stoklossa, C. A., Sharma, A. M., Forhan, M., Siervo, M., Padwal, R. S., & Prado, C. M. (2017) · Journal of Nutrition and Metabolism · doi:10.1155/2017/7307618 · Cited by 121 · see citing works
Understanding type 1 diabetes: etiology and models
Acharjee, S., Ghosh, B., Al-Dhubiab, B. E., & Nair, A. B. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.05.001 · Cited by 117 · see citing works
Batsis, J. A., Mackenzie, T. A., Emeny, R. T., Lopez-Jimenez, F., & Bartels, S. J. (2017) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glx002 · Cited by 116 · see citing works
Osteosarcopenic obesity syndrome: what is it and how can it be identified and diagnosed?
Ilich, J. Z., Kelly, O. J., & Inglis, J. E. (2016) · Current Gerontology and Geriatrics Research · doi:10.1155/2016/7325973 · Cited by 115 · see citing works
Insulin Receptor Trafficking: Consequences for Insulin Sensitivity and Diabetes
Chen, Y., Huang, L., Qi, X., & Chen, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205007 · Cited by 114 · see citing works
Sarcopenia and sarcopenic obesity
Choi, K. M. (2013) · Endocrinology and Metabolism · doi:10.3803/enm.2013.28.2.86 · Cited by 113 · see citing works
Waters, D. L., Qualls, C. R., Dorin, R. I., Veldhuis, J. D., & Baumgartner, R. N. (2008) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/63.5.536 · Cited by 112 · see citing works
Mcternan (2006) · doi:10.1104/pp.92.4.891 · Cited by 109 · see citing works
OUTCOMES OF A CONTEMPORARY AMPUTATION SERIES
Lim, T. S., Finlayson, A., Thorpe, J. M., Sieunarine, K., Mwipatayi, B. P., Brady, A., Abbas, M., & Angel, D. (2006) · ANZ Journal of Surgery · doi:10.1111/j.1445-2197.2006.03715.x · Cited by 108 · see citing works
Sex hormones and skeletal muscle weakness
Sipilä, S., Narici, M., Kjaer, M., Pöllänen, E., Atkinson, R. A., Hansen, M., & Kovanen, V. (2013) · Biogerontology · doi:10.1007/s10522-013-9425-8 · Cited by 106 · see citing works
<p>Mechanism of Traditional Chinese Medicine in Treating Knee Osteoarthritis</p>
Wang, M., Liu, L., Zhang, C. S., Liao, Z., Jing, X., Fishers, M., Zhao, L., Xu, X., & Li, B. (2020) · Journal of Pain Research · doi:10.2147/jpr.s247827 · Cited by 104 · see citing works
Self-citationReactive oxygen species: sources, consequences and targeted therapy in type 2 diabetes
Panigrahy, S. K., Bhatt, R., & Kumar, A. (2017) · Journal of Drug Targeting · doi:10.1080/1061186x.2016.1207650 · Cited by 103 · see citing works
Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors
Saltzman, B. S., Doherty, J. A., Hill, D. A., Beresford, S. A., Voigt, L. F., Chen, C., & Weiss, N. S. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm333 · Cited by 102 · see citing works
Diabetes and colorectal cancer incidence in the cohort of Swedish men
Larsson, S. C., Giovannucci, E., & Wolk, A. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1805 · Cited by 101 · see citing works
Dietary Patterns and Cardiovascular Disease Risk in People with Type 2 Diabetes
Archundia Herrera, M. C., Subhan, F. B., & Chan, C. B. (2017) · Current Obesity Reports · doi:10.1007/s13679-017-0284-5 · Cited by 98 · see citing works
Dietary protein intake in sarcopenic obese older women
Muscariello, E., Nasti, G., Siervo, M., Di Maro, M., Lapi, D., D'Addio, G., & Colantuoni, A. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s96017 · Cited by 96 · see citing works
Berkowitz, K. M., Peters, R. K., Kjos, S. L., Goico, J., Marroquin, A., Dunn, M. E., Xiang, A. H., Azen, S. P., & Buchanan, T. A. (1996) · Diabetes · doi:10.2337/diab.45.11.1572 · Cited by 95 · see citing works
Regulation of Bone Metabolism by microRNAs
Taipaleenmäki, H. (2018) · Current Osteoporosis Reports · doi:10.1007/s11914-018-0417-0 · Cited by 94 · see citing works
Incretins in obesity and diabetes
Chia, C. W., & Egan, J. M. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14211 · Cited by 93 · see citing works
Feng, Y., Fang, Y., Wang, Y., & Hao, Y. (2018) · BioMed Research International · doi:10.1155/2018/3128378 · Cited by 91 · see citing works
Sarcopenic obesity and cognitive performance
Tolea, M., Chrisphonte, S., & Galvin, J. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s164113 · Cited by 90 · see citing works
MMP14 in sarcoma: a regulator of tumor microenvironment communication in connective tissues
Gonzalez-Molina, J., Gramolelli, S., Liao, Z., Carlson, J. W., Ojala, P. M., & Lehti, K. (2019) · Cells · doi:10.3390/cells8090991 · Cited by 89 · see citing works
Self-citationNieuwoudt, S., Fealy, C. E., Foucher, J. A., Scelsi, A. R., Malin, S. K., Pagadala, M., Rocco, M., Burguera, B., & Kirwan, J. P. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00407.2016 · Cited by 87 · see citing works
Sarcopenic obesity: research advances in pathogenesis and diagnostic criteria
Xie, W.-Q., Xiao, G.-L., Fan, Y.-B., He, M., Lv, S., & Li, Y.-S. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01435-9 · Cited by 86 · see citing works
Hassan-Smith, Z. K., Jenkinson, C., Smith, D. J., Hernandez, I., Morgan, S. A., Crabtree, N. J., Gittoes, N. J., Keevil, B. G., Stewart, P. M., & Hewison, M. (2017) · PLOS ONE · doi:10.1371/journal.pone.0170665 · Cited by 84 · see citing works
Myokines, physical activity, insulin resistance and autoimmune diseases
Díaz, B. B., González, D. A., Gannar, F., Pérez, M. C. R., & de León, A. C. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.09.002 · Cited by 82 · see citing works
Prevention and treatment of sarcopenic obesity in women
Petroni, M. L., Caletti, M. T., Dalle Grave, R., Bazzocchi, A., Aparisi Gómez, M. P., & Marchesini, G. (2019) · Nutrients · doi:10.3390/nu11061302 · Cited by 82 · see citing works
Trends in the Prevalence of Diabetes Among U.S. Adults: 1999–2016
Fang, M. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.05.018 · Cited by 81 · see citing works
Bąk, E., Marcisz, C., Krzemińska, S., Dobrzyn-Matusiak, D., Foltyn, A., & Drosdzol-Cop, A. (2017) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph14091073 · Cited by 80 · see citing works
Insulin Signalling: The Inside Story
Posner, B. I. (2016) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.07.002 · Cited by 80 · see citing works
Sammarco, R., Marra, M., Di Guglielmo, M. L., Naccarato, M., Contaldo, F., Poggiogalle, E., Donini, L. M., & Pasanisi, F. (2017) · Obesity Facts · doi:10.1159/000468153 · Cited by 75 · see citing works
Phua, W. W. T., Wong, M. X. Y., Liao, Z., & Tan, N. S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051425 · Cited by 72 · see citing works
Self-citationBackx, E. M. P., Tieland, M., Borgonjen-van den Berg, K. J., Claessen, P. R., van Loon, L. J. C., & de Groot, L. C. P. G. M. (2016) · International Journal of Obesity · doi:10.1038/ijo.2015.182 · Cited by 66 · see citing works
Sanada, K., Chen, R., Willcox, B., Ohara, T., Wen, A., Takenaka, C., & Masaki, K. (2018) · Nutrition · doi:10.1016/j.nut.2017.09.003 · Cited by 65 · see citing works
Vitamin D status is associated with physical performance: the results of three independent cohorts
Sohl, E., de Jongh, R. T., Heijboer, A. C., Swart, K. M. A., Brouwer-Brolsma, E. M., Enneman, A. W., de Groot, C. P. G. M., van der Velde, N., Dhonukshe-Rutten, R. A. M., Lips, P., et al. (2013) · Osteoporosis International · doi:10.1007/s00198-012-2124-5 · Cited by 62 · see citing works
Muscle strength is a marker of insulin resistance in patients with type 2 diabetes: a pilot study
NOMURA, T., IKEDA, Y., NAKAO, S., ITO, K., ISHIDA, K., SUEHIRO, T., & HASHIMOTO, K. (2007) · Endocrine Journal · doi:10.1507/endocrj.k07-055 · Cited by 61 · see citing works
Oh, C., Jeon, B. H., Reid Storm, S. N., Jho, S., & No, J.-K. (2017) · Nutrition · doi:10.1016/j.nut.2016.06.004 · Cited by 60 · see citing works
Yu, S., Powell, A., Khow, K., & Visvanathan, R. (2016) · Nutrients · doi:10.3390/nu8040189 · Cited by 58 · see citing works
Yang, Y., Yang, T., Liu, S., Cao, Z., Zhao, Y., Su, X., Liao, Z., Teng, X., & Hua, J. (2019) · PeerJ · doi:10.7717/peerj.8109 · Cited by 58 · see citing works
Self-citationBerger-Groch, J., Thiesen, D. M., Ntalos, D., Hennes, F., & Hartel, M. J. (2020) · European Spine Journal · doi:10.1007/s00586-020-06292-z · Cited by 57 · see citing works
Emerging roles of β-cell mitochondria in type-2-diabetes
Las, G., Oliveira, M. F., & Shirihai, O. S. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.100843 · Cited by 51 · see citing works
Exercise, Autophagy, and Apoptosis
Mooren, F. C., & Krüger, K. (2015) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2015.07.023 · Cited by 50 · see citing works
Past, present and future of latent autoimmune diabetes in adults
Liu, B., Xiang, Y., Liu, Z., & Zhou, Z. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3205 · Cited by 50 · see citing works
Zhou, X., Xing, B., He, G., Lyu, X., & Zeng, Y. (2018) · Obesity Facts · doi:10.1159/000491797 · Cited by 44 · see citing works
Son, J., Yu, Q., & Seo, J.-S. (2019) · Nutrition Research and Practice · doi:10.4162/nrp.2019.13.1.47 · Cited by 44 · see citing works
Chong, M. S., Lim, J. P., Leung, B., Ding, Y. Y., Tay, L., Ismail, N. H., Yeo, A., & Yew, S. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s78901 · Cited by 43 · see citing works
Xu, Y. X. Z., Xi, S., & Qian, X. (2019) · Journal of Diabetes Research · doi:10.1155/2019/9182595 · Cited by 42 · see citing works
Marrow adiposity and hematopoiesis in aging and obesity: exercise as an intervention
Patel, V. S., Ete Chan, M., Rubin, J., & Rubin, C. T. (2018) · Current Osteoporosis Reports · doi:10.1007/s11914-018-0424-1 · Cited by 39 · see citing works
Shimabukuro, M., Tanaka, A., Sata, M., Dai, K., Shibata, Y., Inoue, Y., Ikenaga, H., Kishimoto, S., Ogasawara, K., Takashima, A., et al. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0571-1 · Cited by 38 · see citing works
Understanding Sarcopenic Obesity in Terms of Definition and Health Consequences: A Clinical Review
Nezameddin, R., Itani, L., Kreidieh, D., Masri, D. E., Tannir, H., & Ghoch, M. E. (2020) · Current Diabetes Reviews · doi:10.2174/1573399816666200109091449 · Cited by 38 · see citing works
Body composition, physical exercise, growth hormone and obesity.
WELTMAN, A. L., Weltman, J. Y., Veldhuis, J. D., & Hartman, M. L. (2001) · PubMed · Cited by 37 · see citing works
Updated concept of sarcopenia based on muscle–bone relationship
Yakabe, M., Hosoi, T., Akishita, M., & Ogawa, S. (2019) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-019-01048-2 · Cited by 36 · see citing works
Shimabukuro, M. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.ed083 · Cited by 34 · see citing works
Berkowitz, K., Peters, R., Kjos, S. L., Goico, J., Marroquin, A., Dunn, M. E., Xiang, A., Azen, S., & Buchanan, T. A. (1996) · Diabetes · doi:10.2337/diabetes.45.11.1572 · Cited by 34 · see citing works
Henriques, J., Vaz-Pereira, S., Nascimento, J., & Rosa, P. C. (2015) · Acta Médica Portuguesa · doi:10.20344/amp.5361 · Cited by 33 · see citing works
Immunoinflammatory mediators in the pathogenesis of diabetes mellitus
Gomes, B. F., & Accardo, C. D. M. (2019) · Einstein (São Paulo) · doi:10.31744/einstein_journal/2019rb4596 · Cited by 32 · see citing works
Flagged first, then by citations
1 of the 211 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement
Donini, L. M., Busetto, L., Bischoff, S. C., Cederholm, T., Ballesteros-Pomar, M. D., Batsis, J. A., Bauer, J. M., Boirie, Y., Cruz-Jentoft, A. J., Dicker, D., et al. (2022) · Obesity Facts · doi:10.1159/000521241 · Cited by 1,019 · see citing works
Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review
Li, C., Yu, K., Shyh‐Chang, N., Jiang, Z., Liu, T., Ma, S., Luo, L., Guang, L., Liang, K., Ma, W., et al. (2022) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12901 · Cited by 626 · see citing works
Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement
Donini, L. M., Busetto, L., Bischoff, S. C., Cederholm, T., Ballesteros-Pomar, M. D., Batsis, J. A., Bauer, J. M., Boirie, Y., Cruz-Jentoft, A. J., Dicker, D., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2021.11.014 · Cited by 566 · see citing works
A Narrative Review on Sarcopenia in Type 2 Diabetes Mellitus: Prevalence and Associated Factors
Izzo, A. C., Massimino, E., Riccardi, G., & Pepa, G. D. (2021) · Nutrients · doi:10.3390/nu13010183 · Cited by 431 · see citing works
PPAR-α Modulators as Current and Potential Cancer Treatments
Chi, T., Wang, M., Wang, X., Ke, Y., Xie, F., Zehuan, L., & Wei, P. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.599995 · Cited by 244 · see citing works
Self-citationSarcopenia: Etiology, Nutritional Approaches, and miRNAs
Cannataro, R., Carbone, L., Petro, J. L., Cione, E., Vargas-Molina, S., Romero, H. M. A., Forero, D. A., Odriozola-Martínez, A., Kreider, R. B., & Bonilla, D. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189724 · Cited by 167 · see citing works
Espino-González, E., Dalbram, E., Mounier, R., Gondin, J., Farup, J., Jessen, N., & Treebak, J. T. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.02.014 · Cited by 132 · see citing works
Sarcopenic Obesity: An Emerging Public Health Problem
Ji, T., Li, Y., & Ma, L. (2022) · Aging and Disease · doi:10.14336/ad.2021.1006 · Cited by 126 · see citing works
Management of Type 2 Diabetes Mellitus in Elderly Patients with Frailty and/or Sarcopenia
Sanz‐Cánovas, J., Sampalo, A. L., Cobos-Palacios, L., Ricci, M., Hernández-Negrín, H., Mancebo-Sevilla, J. J., Álvarez-Recio, E., Lopez-Carmona, M. D., Perez-Belmonte, L. M., Gómez‐Huelgas, R., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19148677 · Cited by 122 · see citing works
Pan, R., Zhang, Y., Wang, R., Xu, Y. Q., Ji, H., & Zhao, Y. (2022) · PLoS ONE · doi:10.1371/journal.pone.0279889 · Cited by 113 · see citing works
Sarcopenia and Diabetes: A Detrimental Liaison of Advancing Age
Lisco, G., Disoteo, O., Tullio, A. D., Geronimo, V. D., Giagulli, V. A., Monzani, F., Jirillo, E., Cozzi, R. C., Guastamacchia, E., Pergola, G. D., et al. (2023) · Nutrients · doi:10.3390/nu16010063 · Cited by 109 · see citing works
Diabetic Muscular Atrophy: Molecular Mechanisms and Promising Therapies
Shen, Y., Li, M., Wang, K., Qi, G., Liu, H., Wang, W., Ji, Y., Chang, M., Deng, C., Xu, F., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.917113 · Cited by 103 · see citing works
Ren, Q., Chen, S., Chen, X., Niu, S., Yue, L., Pan, X., Li, Z., & Chen, X. (2022) · Drug Design, Development and Therapy · doi:10.2147/dddt.s381546 · Cited by 91 · see citing works
Cellular Senescence: Mechanisms and Therapeutic Potential
Liao, Z., Yeo, H. L., Wong, S. W., & Zhao, Y. X. (2021) · Biomedicines · doi:10.3390/biomedicines9121769 · Cited by 86 · see citing works
Self-citationNie, Y., Zhou, H., Wang, J., & Kan, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1245199 · Cited by 85 · see citing works
Pathophysiology of sarcopenia: Genetic factors and their interplay with environmental factors
Aslam, M. A., Ma, E. B., & Huh, J. Y. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155711 · Cited by 74 · see citing works
Volpe, S., Lisco, G., Racaniello, D., Fanelli, M., Colaianni, V., Vozza, A., Triggiani, V., Sabbà, C., Tortorella, C., De Pergola, G., et al. (2022) · Nutrients · doi:10.3390/nu14122414 · Cited by 67 · see citing works
Insights into Pathogenesis, Nutritional and Drug Approach in Sarcopenia: A Systematic Review
Mellem, R. H., Girotto, O. S., Marques, E. B., Laurindo, L. F., Grippa, P. C., Mendes, C. G., Garcia, L. N. H., Bechara, M. D., Barbalho, S. M., Sinatora, R. V., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11010136 · Cited by 67 · see citing works
Szekeres, Z., Nagy, A., Jahner, K., & Szabados, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158214 · Cited by 66 · see citing works
Ageing of skeletal muscle extracellular matrix and mitochondria: finding a potential link
Cai, L., Shi, L., Peng, Z., Sun, Y., & Chen, J. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2240707 · Cited by 60 · see citing works
Chronic circadian shift leads to adipose tissue inflammation and fibrosis
Xiong, X., Lin, Y., Lee, J., Paul, A., Yechoor, V. K., Figueiro, M. G., & Ma, K. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.111110 · Cited by 51 · see citing works
Minniti, G., Pescinini-Salzedas, L. M., Minniti, G. A. D. S., Laurindo, L. F., Barbalho, S. M., Sinatora, R. V., Sloan, L. A., Haber, R. S. D. A., Araújo, A. C., Quesada, K. R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113452 · Cited by 52 · see citing works
Developmental Trends of Metabolic Syndrome in the Past Two Decades: A Narrative Review
Obeidat, A. A., Ahmad, M. N., Ghabashi, M. A., Alazzeh, A. Y., Habib, S. M., Al-Haijaa, D. M. A., & Azzeh, F. S. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14072402 · Cited by 49 · see citing works
Omura, T., & Araki, A. (2022) · Geriatrics & Gerontology International · doi:10.1111/ggi.14339 · Cited by 47 · see citing works
Karthika, C., Appu, A. P., Akter, R., Rahman, M. H., Tagde, P., Ashraf, G. M., Abdel‐Daim, M. M., Hassan, S. S. U., Abid, A., & BUNGAU, S. G. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-17830-7 · Cited by 45 · see citing works
RetractedEngineered hydrogel platform for diabetic wound healing
Cui, J., Shi, J., Liu, Y., Shi, X., Sun, J. X., He, Z., Luo, C., & Zhang, S. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.160379 · Cited by 45 · see citing works
Diagnostic and Prognostic Value of Circulating CircRNAs in Cancer
Wang, M., Xie, F., Lin, J., Zhao, Y., Zhang, Q., Liao, Z., & Wei, P. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.649383 · Cited by 46 · see citing works
Self-citationMetabolic syndrome: molecular mechanisms and therapeutic interventions
Zheng, L., Zeng, A., Liu, L., Tian, W., Wang, R., Zhang, L., Hua, H., & Zhao, J. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00303-5 · Cited by 44 · see citing works
Yoshida, S., Shiraishi, R., Nakayama, Y., & Taira, Y. (2023) · Nutrients · doi:10.3390/nu15132991 · Cited by 44 · see citing works
Gut microbiota and diabetic kidney diseases: Pathogenesis and therapeutic perspectives
Lin, J., Wang, Z., Sun, J.-J., Yang, Y., Li, X., Wang, X., Shi, Y., Zhu, Y., Wang, R., Wang, M., et al. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i4.308 · Cited by 41 · see citing works
Self-citationPhase angle is associated with sarcopenic obesity in post-stroke patients
Yoshimura, Y., Wakabayashi, H., Nagano, F., Matsumoto, A., Shimazu, S., Shiraishi, A., Kido, Y., Bise, T., Hori, K., & Yoneda, K. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.08.018 · Cited by 40 · see citing works
Szczerbiński, Ł., & Florez, J. C. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00232-2 · Cited by 38 · see citing works
Sarcopenic obesity diagnosis by different criteria mid-to long-term post-bariatric surgery
Vieira, F. T., Godziuk, K., Lamarca, F., Melendez-Araújo, M. S., Lima, R. M., Prado, C. M. M., de Carvalho, K. M. B., & Dutra, E. S. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.07.006 · Cited by 38 · see citing works
Sodium-glucose co-transporter 2 inhibitors and Sarcopenia: A controversy that must be solved
Afşar, B., & Afşar, R. E. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.10.004 · Cited by 38 · see citing works
Chuan, F., Chen, S., Ye, X., Kang, S., Mei, M., Tian, W., Liao, K., Li, Y., Gong, L., Li, R., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.10.023 · Cited by 36 · see citing works
Camajani, E., Persichetti, A., Watanabe, M., Contini, S., Vari, M., Di Bernardo, S., Faro, M., Lubrano, C., Gnessi, L., Caprio, M., et al. (2022) · Nutrients · doi:10.3390/nu14091884 · Cited by 34 · see citing works
Li, R., Lin, S., Tu, J., Chen, Y., Cheng, B., Mo, X., & Xie, T. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04261-w · Cited by 34 · see citing works
Association of Body Composition with Type 2 Diabetes: A Retrospective Chart Review Study
Lin, C., Yu, N., Wu, H., Lee, Y.-Y., Lin, W.-C., Chiu, I.-Y., Chien, W., & Liu, Y.-C. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18094421 · Cited by 34 · see citing works
Bays, H. E., Golden, A., & Tondt, J. (2022) · Obesity Pillars · doi:10.1016/j.obpill.2022.100034 · Cited by 34 · see citing works
Implication of diet and exercise on the management of age‐related sarcopenic obesity in Asians
Kim, Y. J., Moon, S., Yu, J. M., & Chung, H. S. (2022) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14442 · Cited by 33 · see citing works
Defining and diagnosing sarcopenia: Is the glass now half full?
Barazzoni, R., Cederholm, T., Zanetti, M., & Cappellari, G. G. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155558 · Cited by 36 · see citing works
Assyov, Y. S., Nedeva, I., Spassov, B., Gerganova, A., Velikov, T., Kamenov, Z. A., & Velikova, T. V. (2024) · Nutrients · doi:10.3390/nu16152560 · Cited by 32 · see citing works
Shi, Y., Zhang, Y., Luo, H., Xu, F., Gao, J.-M., Shi, J., & Gong, Q. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.828473 · Cited by 28 · see citing works
Self-citationSarcopenic obesity — a current problem of modern geriatrics
Kurmaev, D. P., Bulgakova, S. V., & Treneva, E. V. (2023) · Russian Journal of Geriatric Medicine · doi:10.37586/2686-8636-4-2022-228-235 · Cited by 24 · see citing works
Metabolomics analysis reveals serum biomarkers in patients with diabetic sarcopenia
Tan, Y., Liu, X., Yang, Y., Li, B., Yu, F., Zhao, W., Fu, C., Yu, X., Han, Z., & Cheng, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1119782 · Cited by 24 · see citing works
Self-citationRizvi, A. A., & Rizzo, M. (2024) · Medicina · doi:10.3390/medicina60101648 · Cited by 23 · see citing works
Ishimura, E., Okuno, S., Nakatani, S., Mori, K., Miyawaki, J., Okazaki, H., Sugie, N., Norimine, K., Yamakawa, K., Tsujimoto, Y., et al. (2021) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2021.07.003 · Cited by 22 · see citing works
Sılay, K., & Öztorun, H. S. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-06105-2 · Cited by 23 · see citing works
Ginsenoside Rg5 promotes muscle regeneration via p38MAPK and Akt/mTOR signaling
Kim, R., Kim, J. W., Choi, H., Oh, J., Kim, T. H., Go, G.-Y., Lee, S.-J., & Bae, G. (2023) · Journal of Ginseng Research · doi:10.1016/j.jgr.2023.06.004 · Cited by 21 · see citing works
Bathina, S., & Armamento‐Villareal, R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1168687 · Cited by 21 · see citing works
Zhao, Z., Cai, R., Tao, L., Sun, Y., & Sun, K. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1452512 · Cited by 20 · see citing works
Li, C., Li, Y., Wang, N., Ge, Z., Shi, Z., Wang, J., Ding, B., Bi, Y., Wang, Y., & Hong, Z. (2022) · Healthcare · doi:10.3390/healthcare10061100 · Cited by 20 · see citing works
Kalra, S., Mithal, A., Zargar, A. H., Sethi, B. K., Dharmalingam, M., Ghosh, S. K., & Sen, R. (2022) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2022.18.1.63 · Cited by 23 · see citing works
Multifaceted roles of extracellular RNAs in different diseases
Sohail, A. M., Khawar, M. B., Afzal, A., Hassan, A., Shahzaman, S., & Ali, A. (2022) · Military Medical Research · doi:10.1186/s40779-022-00405-z · Cited by 20 · see citing works
Metabolic-associated fatty liver disease and sarcopenia: A double whammy
Viswanath, A., Fouda, S., Fernandez, C. J., & Pappachan, J. M. (2024) · World Journal of Hepatology · doi:10.4254/wjh.v16.i2.152 · Cited by 20 · see citing works
Gender Differences in Body Composition in Pre-Frail Older Adults With Diabetes Mellitus
Merchant, R. A., Soong, J. T. Y., & Morley, J. E. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.795594 · Cited by 19 · see citing works
Gómez, J. J. L., Gutiérrez-Lora, C., Izaola-Jáuregui, O., Primo, D., Hoyos, E. G., Jiménez-Sahagún, R., & de Luis, D. A. (2022) · Nutrients · doi:10.3390/nu14224802 · Cited by 19 · see citing works
COVID-19 associated liver injury: An updated review on the mechanisms and management of risk groups
Shi, Y., Wang, M., Wu, L., Li, X., & Liao, Z. (2023) · Liver Research · doi:10.1016/j.livres.2023.07.001 · Cited by 20 · see citing works
Self-citationRodrigues, P. S., Mendonça, F. M., Neves, J. S., Luís, C., Rodrigues, I., Moreno, T., Silva, D. F., Pedro, J. M. P., Varela, A. T. I. F., Fernandes, A., et al. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07164-x · Cited by 18 · see citing works
A diagnostic proposal for sarcopenic obesity in adults based on body composition phenotypes
Zambon Azevedo, V., Ponnaiah, M., Bel Lassen, P., Ratziu, V., & Oppert, J.-M. (2022) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2022.10.010 · Cited by 18 · see citing works
Ko, C., Wu, C., Huang, W., Lo, Y.-M. M., Lin, S., Wu, J. S., Huang, W., & Shen, S. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3227 · Cited by 18 · see citing works
Perry, C. A., Van Guilder, G. P., & Butterick, T. A. (2022) · BMC Nutrition · doi:10.1186/s40795-022-00516-9 · Cited by 16 · see citing works
Regulatory mechanisms of microRNAs in endocrine disorders and their therapeutic potential
Ledesma‐Pacheco, S. J., Urióstegui-Pena, A. G., Rodriguez-Jacinto, E., Gomez-Hernandez, E., Estrada‐Meza, C., Banerjee, A., Pathak, S., Ruiz‐Manriquez, L. M., Duttaroy, A. K., & Paul, S. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1137017 · Cited by 16 · see citing works
Renin angiotensin system-induced muscle wasting: putative mechanisms and implications for clinicians
Afsar, B., Afsar, R. E., Caliskan, Y., Lentine, K. L., & Edwards, J. C. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05043-8 · Cited by 15 · see citing works
Liu, Y., Sun, G., & Li, Y. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14412 · Cited by 15 · see citing works
Noda, T., Kamiya, K., Hamazaki, N., Nozaki, K., Ichikawa, T., Yamashita, M., Uchida, S., Maekawa, E., Terada, T., Reed, J. L., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11071847 · Cited by 16 · see citing works
Yogesh, M., Patel, M., Makwana, H., & Kalariya, H. (2024) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-024-00179-4 · Cited by 16 · see citing works
Association between dietary inflammatory index and low muscle mass in diabetes/prediabetes patients
Chen, W., Xiong, B., Liao, Z., Xiao, M., & Chen, W. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112258 · Cited by 15 · see citing works
Self-citationA nomogram for screening sarcopenia in Chinese type 2 diabetes mellitus patients
Ming-zhong, Y., Pan, M., Liang, Y., Li, X., Li, J., & Luo, L. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.112069 · Cited by 14 · see citing works
Xue, J., Zhang, Y., Guang, Z., Miao, T., Ali, Z., Qiao, D., Yao, Y., Wu, K., Zhou, L., Meng, C., et al. (2023) · Sensors · doi:10.3390/s23042020 · Cited by 14 · see citing works
Changes in Choline Metabolites and Ceramides in Response to a DASH-Style Diet in Older Adults
Tate, B. N., Guilder, G. P. V., Aly, M., Spence, L., Diaz-Rubio, M. E., Le, H. H., Johnson, E. L., McFadden, J. W., & Perry, C. A. (2023) · Nutrients · doi:10.3390/nu15173687 · Cited by 14 · see citing works
Muvhulawa, N., Mazibuko-Mbeje, S. E., Ndwandwe, D. E., Silvestri, S., Ziqubu, K., Moetlediwa, M. T., Mthembu, S. X. H., Marnewick, J. L., van der Westhuizen, F. H., Nkambule, B. B., et al. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122125 · Cited by 16 · see citing works
Zou, Y., Tang, X., Yang, S., Chen, Z., Liu, B., 周作琼, Peng, X., & Tang, C. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155972 · Cited by 14 · see citing works
Nakamura, S., Yonekura, S., Shimosato, T., & Takaya, T. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.679152 · Cited by 14 · see citing works
Polo-Ferrero, L., Navarro-López, V., Fuentes, M., Lacal, J., Cancelas-Felgueras, M. D., Santos-Blázquez, N., Méndez-Sánchez, R., & Sánchez-González, J. L. (2025) · Nursing Reports · doi:10.3390/nursrep15030089 · Cited by 13 · see citing works
Gao, L., Cheng, H., Yan, Y., Liu, J., Shan, X., Wang, X., & Mi, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.976998 · Cited by 13 · see citing works
Self-citationLow dietary vitamin C intake is associated with low muscle strength among elderly Korean women
Park, C. Y., & Shin, S. (2024) · Nutrition Research · doi:10.1016/j.nutres.2024.05.006 · Cited by 13 · see citing works
Kono, Y., Takegaki, J., Ohba, T., Matsuda, K., Negoro, R., Fujita, S., & Fujita, T. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120298 · Cited by 13 · see citing works
Zhang, Y., Zhang, P., Wang, F., & Xing, F. (2023) · European Geriatric Medicine · doi:10.1007/s41999-023-00822-w · Cited by 12 · see citing works
Kono, Y., Kajita, H., Okada, T., Nakagawa, R., Fujita, T., & Konishi, S. (2022) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b22-00118 · Cited by 11 · see citing works
GLP-1 and Its Role in Glycogen Production: A Narrative Review
Lotosky, J., Jean, X., Altankhuyag, A., Khan, S. R., Bernotas, A., Sharafshah, A., Blum, K., Posner, A. R., & Thanos, P. K. (2025) · Biomedicines · doi:10.3390/biomedicines13071610 · Cited by 13 · see citing works
Arentson‐Lantz, E. J., Deer, R., Kokonda, M., Wen, C. L., Pecha, T. A., Carreon, S. A., Ngyen, T. M., Volpi, E., & Nowakowski, S. (2022) · Frontiers in Sleep · doi:10.3389/frsle.2022.1011930 · Cited by 11 · see citing works
Ida, S., Kaneko, R., Imataka, K., Ôkubo, K., Azuma, K., & Murata, K. (2023) · Endocrine Journal · doi:10.1507/endocrj.ej22-0548 · Cited by 11 · see citing works
Maheshwari, V., & Basu, S. (2023) · Cureus · doi:10.7759/cureus.49601 · Cited by 14 · see citing works
The BET inhibitor JQ1 targets fat metabolism and counteracts obesity
Fornelli, C., Cento, A. S., Nevi, L., Mastrocola, R., Alves, G. F., Caretti, G., Collino, M., & Penna, F. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.02.001 · Cited by 11 · see citing works
Hafızoğlu, M., Yıldırım, H. K., Öztürk, Y., Şahiner, Z., Karaduman, D., Atbas, C., Doğu, B. B., Halil, M. G., Cankurtaran, M., & Balcı, C. (2024) · Nutrition · doi:10.1016/j.nut.2024.112412 · Cited by 11 · see citing works
Wu, X., Chen, Z., Zhao, Y., & Ren, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-82751-7 · Cited by 11 · see citing works
The Effect of Aging on Quality of Life in Acromegaly Patients Under Treatment
Yamamoto, N., Urai, S., Fukuoka, H., Yamamoto, M., Yoshida, K., Suzuki, M., Shichi, H., Fujita, Y., Kanie, K., Iguchi, G., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.819330 · Cited by 11 · see citing works
Multigene Panel Testing in Turkish Hereditary Cancer Syndrome Patients
Ateş, E. A., Türkyılmaz, A., Alavanda, C., Yıldırım, Ö., & Güney, A. İ. (2022) · Medeniyet Medical Journal · doi:10.4274/mmj.galenos.2022.22556 · Cited by 11 · see citing works
Liang, C., Shi, L., Li, B., & He, Z. (2023) · Healthcare · doi:10.3390/healthcare11243146 · Cited by 11 · see citing works
Chrysavgis, L., Mourelatou, N. G., Koloutsou, M. E., Rozani, S., & Cholongitas, Ε. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412130 · Cited by 12 · see citing works
Age‐Stratified Associations of Sarcopenic Obesity With Mortality in Type 2 Diabetes
Yamamoto, S., Hashimoto, Y., Takahashi, F., Murai, M., Yoshioka, N., Saijo, Y., Munekawa, C., Nakajima, H., Kitagawa, N., Osaka, T., et al. (2026) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.70211 · Cited by 10 · see citing works
Lázaro-Martínez, S., Orueta-Jiménez, T. D. J., Vázquez, P. I. A., Castillo-Ávila, R. G., Tovilla‐Zárate, C. A., Hernández-Gil, K. D. C., Quezada-González, R., Magaña, P. L., López‐Narváez, M. L., & García-González, L. E. (2022) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2022.10.002 · Cited by 10 · see citing works
Effects of non-pharmacological interventions on patients with sarcopenic obesity: A meta-analysis
Xu, J., Hu, Q., Li, J., Zhou, Y., & Chu, T. (2023) · PLoS ONE · doi:10.1371/journal.pone.0290085 · Cited by 10 · see citing works
Immunogenetic Aspects of Sarcopenic Obesity
Mazurkiewicz, Ł., Czernikiewicz, K., & Grygiel‐Górniak, B. (2024) · Genes · doi:10.3390/genes15020206 · Cited by 10 · see citing works
Batitucci, G., Abud, G. F., Ortiz, G. U., Belisário, L. F., Travieso, S. G., Viliod, M. C. D. L., Venturini, A. C. R., & de Freitas, E. C. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102460 · Cited by 11 · see citing works
Johri, N., Vengat, M., Kumar, D., Nagar, P., John, D., Dutta, S., & Mittal, P. (2023) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-023-01262-w · Cited by 10 · see citing works
Banack, H. R., LaMonte, M. J., Manson, J. E., Zhu, K., Evans, W. J., Shankaran, M., & Wactawski‐Wende, J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278723 · Cited by 10 · see citing works
Park, J., Kim, M., Shin, H., Ahn, H., & Park, Y. K. (2023) · Clinical Nutrition Research · doi:10.7762/cnr.2023.12.4.245 · Cited by 9 · see citing works
Insulin resistance, type 2 diabetes mellitus and sarcopenia
Kurmaev, D. P., Bulgakova, S. V., & Treneva, E. V. (2024) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-222-2-141-148 · Cited by 9 · see citing works
- Authors
- Wang, M., Tan, Y., Shi, Y., Wang, X., Liao, Z., & Wei, P.
- Affiliations
- Beijing University of Chinese Medicine (CN)
- Nanyang Technological University (SG)
- Corresponding author
- Liao, Zehuan
- Wei, Peng
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2020-08-25
- Volume
- 11
- Pages
- 568-568
- ISSN
- 1664-2392 (ISSN-L)
- PMC
- PMC7477770
- OpenAlex
- W3080775941
- Semantic Scholar
- 2dbb99ea4d500bf11a4b6eb291efdb9f2160d471
- Cited by
- 231
- References
- 211
- Citations by year
- 2026: 33 · 2025: 45 · 2024: 45 · 2023: 47 · 2022: 50 · 2021: 10 · 2020: 1
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Endocrinology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- DR-NTU (Nanyang Technological University) (submittedVersion, cc-by)
- Funders
- National Natural Science Foundation of China (31800652, 81904049)
- Topics
- Health Sciences › Medicine › Physiology › Nutrition and Health in Aging
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- sarcopenic obesity, diabetes mellitus, pathogenesis, aging, physical inactivity, malnutrition, low-grade inflammation, insulin resistance, impaired insulin secretion, fasting blood glucose, oral glucose tolerance test, HbA1c, diagnosis, treatment, diet, physical activity, antidiabetic drugs
- MeSH terms
- Insulin Secretion, Aging, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Obesity, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review